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ABS TRACT 
Imidazo le - 4 , 5-di carboxylic a cid, di -2-mcthylhydrazide (JNT.Va) ,• 
exemplary of several recently synthesized dihyd1·az-idcs , was inves ti-
gated for po ssible m .onoamine oxidase inhibi tiug propertic s. A signifi -
c ant aH:er;:i.tion of systemic blood pressure, nieasurcd both directly 
and indirectly, was not evident during either single of r c p e 2.tcc1 
adrn:i.ni..;:;b:ation of JNlVa at low dos e s . Mono a1ninc oxid ;:;.sc, as 
deterr::ij:wd f p 0 ctrophoto1netrically , was inhibHed iE. yi.t1·~-' bi.it not 
i n vivo by this cornpound . The degree of enz ym e inhibit.ion ·w<ls show·u 
to be d e p endent upon preincubation time . Cornr,oun d JNJVa was l ess 
effective in inhibiting monoaminc oxidase in_ :::_iLr~ ih<:in was phenel·· 
~·.h·ic~ , a kno\,·n inhibitor of nioDc:2.rDinc o~ddase both in_ vivo and 
i n vit:.:-o. \,\~h'o n ~_,_easured 1. 0 hour and 2. 5 ho lne after drug adrninistra-
tioP, phc-r1 •> izine inc1·ease c gross loconwtor activity at bDJJ-1 tirn'~ 
i ntervals, whereas .JNTV ;:: significanLly ciccrea.sed sponianc-:-nis 
<.cHvH.y < t the 1. 0 l-rnur :i1-.ie inLcr ral. 
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I n 1964 , Dr . Jay Nc1natollahi 0'.' syn the sized a series of irnidazolc 
a c id hydrazide s . C omparison o f the rnolecular structures of t::ic se 
i midazolecarboxhydra7.ides with no"\vn bycirazid~ -type inhibitors of 
mo lOarnine oxi dase (MAO) suggested the hy polhc sis that this series of 
c ompouw £., nligh·s exhibit sim.ilar biological activity . In ord2r t0 test 
the v 2lU:ity of ihe hypothesis , an approach was rnadc bc..c;~~d en £"'VC:ral 
as .surn.piions: e)'.f1t:' riments w i th t h e <: e c01npounds should provide c orn -
p a ri sons with the phannacological acti,riti.:!S of known inhibitors of 
M AO, e . g . , t he pro l ongation or p otentiat:on of the efie els elici ted by 
v arious biogenic an1ines to produce t e type of acti·.)n that may mani-
fes t it self b y an alteration i n systemic blood p1·essure ; second, the 
cxperi1nents should include both i ::i vivo and in itr _ studies of live1 
m onoa1nine oxidasc i n rats pretreated with suffident doses of 
h y<lrazide MAO inhibitors , si~1ce ther;c cr;1nr;ou nds have shown that 
the activity of this enzyme system is ciLh::r grea.:ly cepres.scd or 
inhi bited compicte ly ; and the c~xpE:rir11e:1ts should a ll ow for obsci-va -
tio r:.<. of behavi oral changes (".:suall y an in(.l'easc i !1 l o c ornot:n 
a ct!.vity) such as have been observed i n several ani n1al species 
tr eat. e el with MAO inhibitors. 
':'Unive rsity of Te x as; Drug-Pl.:.c8t.i.c Research and Toxicology 
Laboratories , Balcones Rcse a:-ch Center , Austin, Texas 
.Consequently, tes t procedures were desi gned with the purpose of 
detc rmining which, H any, of these physiologi cal alterations could 
b e den1onstrated ju aniinals treated with new con~pounds from this 
s eries of acid hydr a:r.ides . 
II. SURVEY OF TIIE LIT ERATURE 
The prelimi11ary observations of Zeller et a l. (19 52 ) of two anti-
tubercular drug s , isonicotinic acid hydrazide (INH) and 1-i sonicotinyl-
2-isopropyl hydr azide (IIH) p roved to be th e initialing stinrnlus for 
subs equent studies of hydr ?.zid e s and thei r effcc l on the enzyme, rn.ono -
2rninc ::ixid as<::. Teller and his coworkers nokd that the two c.d d 
hy d;:;.izide s p :L"o~1u cc d marke d in -yitro iuhi bi ion of mamn-1a J:i.an rnono -
an1ine CJ>:idase , c.nd attributed the euphori.3. ob served in patients duri ng 
clini c a l t rials with these drugs, to syrnp<itl:ctic stirnulation resulti ng 
fr om jn tcrferenc.e of norrna l amine n1.eta b o li srn . 
Studies on the: cellula r lo calization of rnonoa.1nine oxjdase 
(Hawkin s , 1952) r e vealed t hat enzyn1.e activity was l arge ly present in 
the mit.ochondd a . Follov..ring this observation, Zeller and Bar sky 
(195 2 ) po s tulated t hat administration of 1 -isonicotinyl-2 - j sopropy l 
hydrazine (Ipr oniazicl ), foll.owed by i solation of t is sue rnitochonclria for 
d e t errnination of monoarojnc o x j dase activity, would provide a11 indic a -
tion of any i~ vivo enzyme inhibition. Under these conditions , Iproni.a -
zid p r oduced an i rreversiLle inhibition of liver rnonoan1.ine oxidase , 
both i n vitro and i n vivo. Based o n these fi ndings , Zeller stated: 
"The eli1nination of mono amine oxi <lase activi ly in vivo should 
p rove of value in the investigation of the physiologica . 
function of the cnz.yrne, parlicularly •vi.th regal'<l t o its 
po ss i bJc role in the d e gradation of epinephrin e nd nor -
epinephrine . INH rnay well b e corne o f the same i mporlance 
as h ::i.s c serine in the analysis of Lhe cholincrgi c sys1.e1Yi. 
The aboYe results inay also offer an expbnalion for the 
sympathetic and general rnc1 tal st:.mulation observed 
after administration of i so 1.icotinyl - hydrazicle s ... in that tl1e 
b locking of rnonoa1nine oxidase activity coulci lead to an 
accumulation of sympathetic am.ines v.'ith ensuing effects 
o n the autono1nic nervous systen1.. 11 
S chayer and Smile (1953), using 0( - l aballed 14 C-epinephrine, 
den1onstrated the ability of iproniaz.id to aJter epinephrine rnetabolis1n 
4 
i n the intacl rat. In a later study, Schayer (1953), using 14 C-tyrarnine , 
furlLer d emo!1s lratc d that , in contra st to epinephrine , tyrr.unine is 
m e tabolized ahuost solely by rnonoarnine oxida sc ; c:on.se guently , by 
administering radioactive tyramine to rats pretreated with a hydr2.-
zide MAO i nhibitor , and measuring the quantity of unmclabolized 
tyraniine p resent in the urine , he was able to measure the degree of 
in vivo l.1.AO inhibition. Schayer note cl w.i. th interest the obvious 
f ailure of c01npounds capa ble of inhibiting MAO i n vitro to perform. 
the sa1ne f unction in vivo and attributed this l oss of activity to the 
i nability of the drug to reach the site of action b ecause of r apid destruc -
tion or of permeability problems. H e suggested t~c possibility that 
i n vitro preparations underwent so1n.e alteration of the active portion 
of t he enz.yrne , effecting a response different fro rn that seen in an 
i ntact preparat ion . 
Subsequent investigations h a ve reveale d a nmnber of factors which 
c ould conc e iv a bly alter the activity of hydrazid e MAO inhi bi to rs, 
depending upon the type of e xpe rilnental system invo lve d . The 'vvork of 
Acbi (1962 ) demonstrated that. the degree of MAO a.ct.ivit-y and MAO 
·~ 
inhibition involved in an i n vitro preparation j s dependent upon t h e 
st ructural state of the mitochondria . Referring to i nconsistent 
v a lues reported by investigators using both i~ viv~ <rnd i n vi tr<?__ 
sys tems for studying MAO , Aebi noted that, 11 lt is very di.fficult lo 
e xtrapolate figures for an enzymatic activity obtained fr oi n lysed 
p reparations t o the i ntact c ell , if the enz y1ne i s struct rc-dly b ound. 11 
I n r d<·.tion i o i~~ 2.J vo_ studie s of MAO activit) and M l\O inr1ibition , 
I-Ior:it o. (11)65) re p orted that r ed b bod c e ll s arc c.anablc of antagoniz -
ing the acUons of various monoamine oxid<i s e inhibitors . This f act or 
alone might account for variations i n the response to hyclrazide 
i nhibitors , since mitoc 10ndria l p ;: ep.:i.:rations , properly p r epared , do 
n ot contain r ed blood c ells . 
Z e l ler ct ~l., (1 955 ) l ater elucid ::i.ted the rnecha. nis1ns i nvolv e d 
i n the process of MAO inhibition . Zeller r epor ted cc rtai n cha racter-
isU cs of h ydrazi de -type MAO i nhibitors which would subse que ntl.y 
prove to b e almos t universal for thi s cl.ass of compounds. He not.e el 
t hat the d e gr e o f i nhibition of monoa1nine oxidase acHvity depended 
u pon whether t he inhibitor us ed , i n this case 1-isonicotinyl -·2 -isopropyl 
hydrazide , was added to the system prior t o or simultaneously with 
the substrate. In additional e A.-p e rilncnts , preparations of mito-
c hondrial n1.onoan 1i.ne oxida se were prcincubate<l with the inhibitor for 
v a r ious tin1e interv al s prior to the addition of substrate . 
Fro1n tliis work , Z elle r wa s able t o d c.: rr10nst ni. te cic arly thal 
5 
Jhe degree of inhibition of initochondrial MAO was dependent upon t he 
l ength of time t he i nhibitor was allowed access l o the enzyme in the 
absence of substrate. The MAO activity of li vc r h cnnogenate s was 
reporte d to be re l atively unaffecte d by ip roni azid. Thj s apparent 
in sensi tivi ty lo agents capable of inhibiting inonoarnine oxidase in 
vivo was attributed to the presence of a substance or substances 
ir1 the c cllul >1 r ;·1-c' ctions of t he homogenate . S ince ipronic.~z i.d was 
known t::> p1-~H:l".Ce. a p otent , ir rev0rsible i nhibition of MAO i n vivo 
(Z e1ler, ~~· , 1952 ), it seeme d that these i nterfc1·i11g substances did 
not come i nto play i n the intact animal. 
The work of Briesmer and We1ls (1 956 ) descri b e d the ability of 
iproniazid to decrease epinephrine i naci..ivalion b y i ntact liver slices 
fro1n cats pretrealed with the jnhibilo1. However, these authors c on-
eluded that the drug was rclativeJy irnpotent when u se d in an in vit ro 
enzyme preparation. 
l'v1e chanism. of action : i pro21iazid . Although numerous inve stigator, 
6 
h a d u tilized t he hydrazide MAO i nb ibitor s as too l s in studies associated 
with this enzyrne , little was actua lly known a bOl'.t the mechanism o f 
action of these drugs p r ior t o t he publication of the work o f Davison 
(1957). He extended Zeller 1 s original observations , proposing oxygen 
a s a :aecessary requiren1cnt for iproniazic.1, if the drug i s to exhibit 
irreversible in hi bi lion of mitochondrial n1onoamine oxida se . This 
a ctivity is ahsC'nt und e r anaero bic conditions . In accordance with 
previous observations, he found that prog ressive inhjbit.ion of enzyrn.e 
activity was l ess pronounced in liver suspensions as cornpared to 
initochondrial prepara tions. The f a cts that the inhibition reaction 
proved to be first-order and posses se d a high energy of activation, 
strongly suggc sted the occur:.: ence of a chernical r eaction i nvolving 
:the hydrazi<le moiety . 
M a:i tre (l <.;Ci 7 ) studied the effc cts of varit)us MAO inhi.bj Lor s on 
b rai:1 , liver and heart , using two substrates , tyra1nine and 5--hydroxy-
trypta1nine . In order to gain a more complete pi clu1e of i nhibitor 
potencies, he det.erm.ined MAO activity in vivo as well as in vitro . In 
his study _in yivo effects of iproniazid 0:.1 brain 1'.1AO proved io be 
r e l 2.tiveJy mor e potent than those eL;_citocl in vitro . A selected accumu-
lation or a slow n1etabolic rate of the i nhibit.or in the brain weJ"e 
n1.echanisms thoughtio be responsible for this action. However, a 
different the ory is presently favored by the majority of i nve siigaior s: 
ipronazid and rclri.ted hydrazine drugs could uncl e rgo a clc av age of the 
p arent molecule, leading to the formation of an active metabolite ; the 
metabolite then could disappear inore slowly fr om the br ain than from 
p e rip he ral tis sues (organs). Re search in this area h as b een extensive . 
D avi son (19 58) reported that iproniazid and presumably other hydra -
zi<le MAO inhibitors react at Lhe active center of the enzyme i n a 
manner si1 ilar to substrate oxidation . O nce alt.ached to the active 
center of the enzyrne , the drue under goc s clehydrogenati on and reacts 
7 
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furlhcr with the enzyrne to pro<luce the final inhibit.ion. The following 
mechanism was p ostulate d: 
CHME..., 
<, 
CHlviL z CME 2 / CMEz 
- 2H,~E · · 
[E ] + NH ------"-
I 
NH•R 
E• .. NH 
I 














Follov...J.ng this work , Sn1ith et a l., (1962) presente d evidence that , 
du ring the prcfr,L.·J.balion p eriods with the enzyme required for rnaxi1nal 
inhibition, iproni.azid was hydrolyst d to fonn a volatile corn.pound b e -
lieved to be the active inhibitor of the enzy1ne . The reaction was thoug.hl 
to b e non-enzy111atic . Monoan1ine oxidase was not i1npJicatecl in t his 
re action since the fonnation of active inhibitor is accomplished in the 
absence of active enzyrr1e. Isop ropylhydrazine , a rnetabolite of ipronia -
zid ~Coechlin and Iliev , 19 59) with MAO inhibitory properties (Biel ct al. , 
1959; N a ir, 195 9), is b e lieved t o b e the active inhibitor. 
A m .e chanism analagous to the one propo sed f or iproniazid has 
b een reported by Schwartz (1962), who suggested that isocarboxazid 
(Marplan ) exerts its MAO inhibilio n by undergoing hydrolysis to b enzyl-
hydr azine , du r ing prcincubalion with th e enzy1ne . When bcnzylhydrazine 
was u se d a lone , no preincubalion p eri od was necessary to attain n1axirna l 
9 
inhibition of the enzy1nc, in vH1·0. He concluded that the parent mole-
culc must be hydrolysed to the active mojety before inhibi!.ion of the 
enzym.e can b e accon1pl-i.shed . 
Support for a hydrolytic rnech2.nism. involving m onoarnine oxidasc 
has b ee n presented by Seide n and Westley (1963), who used a prepar-
ation of lysed brain mitochondria to show tha t addition of ipro niazid to 
a functio .ub.g MJ.,O rca<.:l5on resulte d in an inhibition of that cystem only 
af.'.::er a. cl:finit.c d e l a y period . In the sarne system , isopropylhyclrazir,e , 
the proposed active moiety of iproni.azid , proved to be t e n times as 
potent as the active compound. Except for the absence of any del a y 
phenorncnon, isopropylhycl ra,-;inE.. elicited the same type of i nhibi t jon 
as that seen with ip roniazid. The postulated inechani sm is summarized 
in the followir,g reaction s : 
(1) IPRONIAZID + H 20 -- - -- - ---> ISONIC O TINIC ACID 
+ 
ISOPROPYLHYDRAZINE 
(2 ) ISOPROPYLHYDRAZINE + MAO - -> INACTIVE FORM 
O F MAO 
According to the schem.e, iproniazid is first rnodifiecl enzy-
matically to fonn an inhibitory product, with subsequen t inlii.bition 
of the enz.yme by the p roduct. This proposed mechanisJY1 of act.ion 
could explain several cha racteristics associated with hydra z ine -
induc e d inhibition of rnonoamine oxidase . 
Hydrazide s: Heino dynamic -~j.fe .£!:__~ 
The effect of hydrazidc MAO inhi1:)itor s o n systemic bJood 
p:::-c 3su::rc is not well unders-too<l . Sjoerdsrna stc:i ted (1960) tha t the 
simulta neons drug-induced decreased blood pressu1·e and increased 
tis sue l evels of norepinephrine " cons titutc c.1 an intriguing paradox ". 
Follov;.r:i.ng clinical reports of th ~ anti.hypertensive effects pro -· 
d 11r.:ed by v a:r.iu .. :f.· hydrazides , G ertner {1959; 1961) found uat certain 
hyclra :~i de 1'.1AO .'JJ.hibitors blocked ganglio11i.c t ransm.ission. Goldberg 
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et al., (1960) noted tha t these c o1npounds exerted a selective i nhibi -
tory action on the sym.pat hetic.: synapse without depressing para.-
sympathetic ganglia. He speculated that tMs sympathetic inhibition 
could be the n'echanisrn responsible fo r hypotension in n1an aftc r 
administration of MAO inhibitors . Ges sa £~~~· , (J. 963 ) postulated 
another theory c oncerning hypotensive effects produced by hydrazide 
l\1AO i nhibitors . These workers noted that hydr azine MAO inhibitors 
elicit c ertain bretylimn-like properties , that they prevent gu.anethidine 
from releasing h e art norepinephrinc, and that they also prevent syn'-
p athetic nerve impulses fron1. releasing norcpinephrine onto receptor 
sites . These findings suhsta11tiale d the work of Davey~ al. (1963), who 
reported that the MAO inhibitor nialarnide reduced the a1nount of nor-
epi n ephrine released frorn splenic nerves by electrical stimulation. 
These effects appeared to be independent of the MAO inliibiLory 
properties exhibited by these co1np oun<ls . According to Ge s sa ~ al. , 
J ] 
(]963), blockade of this cnzy11-e syst rn. could be regarded as an undesir-
able side effect of these drugs in their use as hyputensive agents . 
Clinical investigation by Assali and Kanakbccna (1960) l e cl them to 
conclu<le that the hypo tension as sociat.ed with the use of iproniazid rep re --
sented a sicle effect of the cl rug, probably caused by venous pooling and a 
decrea~1e in c-ar<li ac output. An alternate mechanism. for the production 
of hypote~1sion \-Ices posLulatcd by Sjoer<lsrna (1960) . In studies with various 
hyclra :;.;i r,(: - nd non-hydrazine MAO inhibitors he observed a uniform 
hypotensive effect when evidence of MAO inhibition was apparent , exclu-
sive of the type of inhibitor used. These findings offered evidence of 
a causal relationship b etween lvlAO inhi.bition and reduction of blood 
_pre£sun:. . Fu rther, he pos tulatcC:: that an accunJ.u lation of an arnine , 
such as serotonin , 5-hydi oxytryptamine (5-HT), i n sympatheii c g a nglia 
c ould be responsible for the effects seen in man. Conse quen t ly, dopa-
n1-ine, an excellent s ibstrate for MAO and a weak pressor substance 
c ould accum:rnulate at nerve endings and cornpetitive ly block the action 
of released no1·epinephrine . Kopin ct al. , (1965) have de1nonslrated 
the existence of a weak pressor an1ine , octopanline ( norsynephdne), 
which could produce partial sympathetic blockade by replacement of 
nore inephrine . Thus octopa1nine could act as a fals e , i nactive 
n eurotransmitter . The appeal of this theory h as been augmented by 
the fact that the forrn2.tion of octopamine is enhanced during inhibition 
of MAO . Sjoerds1na (1966) , wl1ile disetrnsing the relationship existing 
between i nhibition of a given enzyme and concurrent pharmacologic 
effects, stated that "such a relationship seems esta blished with the 
MfO ~.1' fi.ibitors. 11 Pletsc.bc-r (1966) noted that only those hydrazine, 
MLO inhibitors capable of exerting a potent inhibiting action on MAO 
i nduced hypotension in man . A number of investigators h ave f ailed 
t o establish any correlation between MAO inhibit.ion an. cl pharmacologi-
c ai effoct s in rna~1. Their f ailure docs not iinpl y that a rclat.io:::iship 
'
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.oc: s \1.o t ex} i;t, l<oweve r , since MAO activity i n rnan has been 
rneasur ed only in peripheral tissues. 
MAO inhibitors: Behavio_~· al changes 
Gylys £.!.al_., (1967) stated that: 
11 1 he monoamine oxidase inhibitors as a pharmacological 
gronp exhibit heterogeneous and unpredictabl e effects 
on spontane ous n101..or activity ...... It is c onceivable 
that s uch heterogeneous responses n-iight b e partially 
due to the chernical diversity o f MAO inhibitors as a 
group and the c>...rperimental d e sign, i. e ., dose selection, 
time of testing, duration of activity r ecording . 11 
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Since 1959 , extensive work h as been undertakeu in an atternpt to clarify 
the mechanis1n of action of hydrazine and non-hydrazine MAO inhibitors 
in relation to central stirnulation. 
The extent to which the therapeutic effects of the inhibitor s , 
particula rly antidepressant actions , may be attributed to the i rrevers -
ible blockade of MAO and the consequent accu1nulation of brain amines 
has been and rernains the question at hand . Feldstein (19 65 ) in his 
discussion c once rning MAO inhibitors and their cJini.cal application 
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posed the question, "Is 1v1AO i nhibition a general pharn1.01cologic 
property of these agents, 01· is it· specifically related to relief of 
dc1wession ? 11 
Nu1ne. rous i nvestiga tors workj ng on hydra z ine -type MAO inhibi-
t ors h ave attern.pted to correlate clinic;:-llly observed behavioral effects 
with several biocheinical changes produced by these drugs, pariicu-
larly ir:c:.cas;~~s in brain amine levels . 
Clinic2.l:y; •,he inood elevati.ng or antidepressant actions of 
hydrazine MAO i nhibitors accompanied by a corresponding jncrease in 
c ertain brain a1nines is readily d e monstrated . Feldstein (1965) used 
t i • f 11 d . . t d 14 c s . 14 c ... h d .1e conv _rs1on o ora ya m1n1s ·ere - eroton1n to -::>- y roxy -
indolaceiic acid, as a qu a ntitative i11dex of MAO inhibition 1nhuman 
subjects, a l of whorn were bejng trei'tte d for p s ychiatric disord e rs. 
Following treatment w i th phcnelzine , i socarboxazid, and nialamide, 
all hydr azine-type MAO i nhibitors , F.eldstein was able to derr1onstrate 
a direct correlation between the degree of drug induce d MAO inhibition 
and clinical irn,.n ovement . P cil'e (1 966 ) was able to rneasure serotonin 
b rain levels directly and antideprc ssant activity of MAO inhibitors in 
44·pat.ients dying of tcrrnjnal illneBscs . He found that br a in serotonin 
levels ros e at the same tim.c that the antidepressant effect of the drug 
o ccurred . 
Studie s in animal b ehavior as sociatecl with brain a1nine levels 
have been inconclusive . Spe c.Lor~~ al, (1 960) studied the effects of 
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several hydrazine l\1AO inr...ibitors, including iproniazid, on bra.in 
l eve l s of norepinephrine and serotonin in various aniinal sp<3cie s . Tbey 
co ncluded from this sh1<ly that an) cer1tro.l excitation elicHed by these 
co1npounds , ~.E. sc or by any accurnulation oI brain serotonin alone, 
was unlikely. I n rabbits, sillgle doses of inhibitor had produced a 
marked rise in br2in serotonin levels. Ho vever , behavioral i:-banges 
dnd ng this pi: r:l) d. \•,rere not evident. Daily dosl..!S of inhibilo:;:, although 
rwt incrP.z. sL>.g s~·roLonin level s significantly higher than single doses, 
did produce a higher norcpinephrine level. It was further noted tha t, 
when p e <•k nor epinephrine levels were obtained, the rabbits elicited 
signs of hypercxcitabiiity . Tbe i nhibitors increased brain serotonin 
] cv-21.E: bnt failed to raise 11orepinephrine levels significantly in cats and 
do gs. It was of interest , then , to note that the i nhibitors failed to 
elicit i ncreased psychomotor activity in either of these species . 
The cffe cts of iproniazid, along with othc r hydrazine - type MAO 
i nhibitors, on locomotor activity in mice remains unclear . Greig 
et a.l., (1 961) reported that iproniazid and b-phenylisopropy1 hydrazine 
(JB 5 16) failed to increase spontaneous 1notor aclivHy when admini -
stere d t o mice . B-phenylisopropyl hydrazine, a hydrazine analog of 
amphetanrinc h as been shown to elicit ce11tral excitation an<l c onvulsions 
in r abbits (Spector, et al. , 1960 ; Ma ling E al. , 1962). Greig ct al. , 
(1 961 ) reported thal this dncg failed to increase spontaneous m .otor 
activity in mice. However , Plun~mer ~al., (1 963 ), using a modified 
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jiggle c age to measure gross locon1o tor activity, noted Lha.t JB-516 
sharply augmented spontaneous activity in mice at the 20 mg/kg dose 
l evel. This effect, they believed, was apparently unrelated to the MAO 
inhibito ry properties o.f the drug, since this stimulatory action dis-
appeared after one hour, whereas lli1AO inhibition rema i ned . Nardil 
(phenelzine ) h as b ee n shown to raise bra~n seroton~n levels i n mice at 
a sl1:!aC. :;r sL·de o[ 0 . 43 ug/g of brain wet weight. (Dubnick et al. , 1959) . 
Acl1n.inis Le red in single do sc s, phene lzine p rocluc.:ed centra l stimu) ation 
in mice , but fail e d to elicit similar responses in rabbits , dogs, rats, 
and monkeys (Chessin et a~. , 1959). 
Rece ntly , Gar attini et al. , (1967) reported a change in turno\·cr 
rate of 5-hydroxy-tryptal'nine in grouped and isolated aggresive mice 
treated with a MAO inhibitor. An i ncrease in turnover time of 
serotonin of about 57% in isolate d mice as compared t:o grouped ·rnice 
was noted. It was furthe r demonstrated that changes in 5-l IT turnover 
are not necessarily reflected in the l eve l of brain 5-HT . Under isolated 
conditions , all mice b ecame aggressive , s ugges ting a possible correla·· 
ti.on b etween behavioral changes and c entral rndabolis1n of S-HT . 
Randall and Bagdon (195 9) re ported that i n mice pretreated w ith 
i prouiazid, the c entral excitatory effects of 5-hyclroxytryptophan and 
DOPA we r e potentiated , whereas the drug f ailed to elicit an excitatory 
response in these anilnals when aclrni.niste red alone . Sin1ilar ly, 
Green (lq6z ) <lcn1onstr atc d that even after repeated oral adm.inistrat.ion 
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of ip roniazi d in high doses (100 mg/kg), no significant or c onsistent 
effect upon the rnotor activity p atte r n o~ the drug -tr eated ar1irn.a] s was 
observed. Conversely, Ches sin~ al. , (195 9) reported that administra-
tion of a single dose of Nard-il (phenelzinc } produced stimulation of the 
centr a l nervous system in mice, but failed to do so in rabbits, dogs, 
c ats, and monkeys . Recently , it h as b~en reported that rnarked 
s Urnula.f.ion pi:oc:_u.ced by at least one MAO inhibitor and ch aractel'ized 
by hype:-actiyity is better developed 2.ncl hence n1ore readily de:rnon--
stra tcd in mice than i :n r ats (Gyiy s ~:.!:_ .?-l.· , 196 7). 
Furguiele (1962 ) measured the changes both i n spontaneous and 
forc ed rn.otor activity in mice f ollowing administration of i .roni2~zid 
a nd phcnyli sopropylhy<l ra zine (PIH) . Potent stirnulatory effe c ts on 
gro ss locomoto r activity were seen aft.er 'PIH administration, whereas 
ip r oniazid greatly depre s se cl spontaneous activity) at high dose l evels . 
Both of t he hydrazide s , however , de creased fo reed activity , as 
m easur ed by "rotorod p e rformance time." These data supported 
existing theori es concerning the rn.ech nism of action of i.he hydrazide s. 
Increased spontaneous activity p roduced by phenyli sopropyl hydrazine 
coin cided with re ports of a dua l 1nechanisrn of this drug; that is, an 
amphe t amine -like direct stinl.ulation of the c enlral nervous sys tern 
accompanied by MAO i nhibition i n the brain (Brodie et al. , (195 9). 
In general, exploratory behavior in r ats i s used as the qualita-
tive measure1nent in determining th e effects of centrally acting drugs. 
Marriott and Spencer (1965) ised a specially designed Y -shap0.d box 
to test behavioral changes in rats following __ administration of phcne l-
zine and other drugs . By this rnethod, the count of the number of 
complete entries with all four feet of the animal into the arrns of the 
b ox is taken as a measurem~nt of exploratory act_ivity . A period of 
35 r:ninutes is allowed to elapse following 2.drninistration of drug 
before H-.2 anirn .::. l is placed into _op.e arm of the box and observed 
c ontinually fox L~ VE' rnirrui:es . Unde r these test conditions , phenelzine 
was. shown to reduce exploratory ac6vity in rats at intermediate dose 
l eve l s of 5-10 1ng/kg, intraperitoneally. The author states : 11 It is 
p ossible that the antidepressant actions of these dru gs are mediated 
through c~i.anges in the metabolism of centrally acting catecholamines 
and may therefor e increase the susceptibility of rats to environmental 
s timuli . " 
Hall 1 s open-field test (1 934) is the one gene rally accepted as a 
valid measure of anirnal behavior , particularly exploratory activ-ity . 
The 11fie l d 11 consists of a circular b ase which is divide d by painted 
squa res. During the allotted ob ervation p eriod , the total number of 
squares traversed and the number of central squares entered by the 
animals are counted . The "t 11 t est is then used to compare values 
gene rated by di·ug --injected animals \Vith corresponding control value s . 
Using this test, Briinblecombie (1962) was able to demonstrate that 
phene l zine d e crease d an~hulatory a ctivity . 
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To s tudy the effects of antidepressant drugs o n l earning, Latz 
et a l. , (1 967 ) pla ced mi c e i n a single - T wate r inaze. Fo _low ing 
administration of various drug s , :,nclu<ling i proniazi<l and phene lzine, 
they dcmonstraled that phene l zi:1e was c apable of iin pairing responE?e 
acquisition, \vhereas iproniazid wci. s not. 
A seemingly biphasic action of s everal MA O i nhil:d.Lors on loco -
rn.otor acfrvity ·:i.as re cently b een repor ted by Gyly s and 1\1uccia (1 967) . 
In~tjally, p!1el'cJ. zine -tr eated mice exhibited a decrease in spontaneous 
activity as m easured by photocell equipped activity charn.be rs. How-
ever , the initial depression was followed by a se c ond p hase charac -
t eri7.ed by hyperactivity . When co rnpared to t he action of cl- ampheta -
mine, it y;as notc•d that the secondary excitatory effects of the MAO 
i nhibitor!:' were dissimilar to the imme diate excitatory r espo!1.se 
e xhibited by t his drug . This secondary action of tlie MAO inhibitors 
suggests the possibility of an indirect - ct.io n of this class of drugs , 
unre l ated to their MAO inhibitory properties. C oncurrent with this 
idea , il was fu rther no ted that do ses of the i nhibitors capable of pro-
du cing hyperactivity were higher than tho se rJoscs requi red for MAO 
i nhibition alone. 
The foregoing review of t he literature makes it apparent that, 
although a sub stan.ial amount of i nforrnation c oncerning hydrazide 
inonoam.ine o xida se inhibitor.s has been publishe d during the past 
cleca cl e, m any f acts concerning this cln.ss of drugs re1nain bo Lh 
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elu s ive and obscure. At present, the trend of research in this fi e ld 
s eems to be foward the · e lucidation of p iarrnacological effects 
elh:itecl by these drugs but which are nevi believed to bt" unrelated 
to ~heir MAO inhibito ry proper lies . 
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III. INVESTIC"!ATlON 
A. O bjectives 
During the p ast decade , nun1erous hydra zide analogs h ave been 
synthesized and e x tensive ly tested to dc t eirnine any po ssil>l e inhihi-
to ry acti on on the n10na1nine oxi ase enzyrne system . It is \vell 
e stabH shed that nun.~crous compounds possessing the hydrazi.de moeity' 
are capa ble of i rn::ver sibly i nhibiting :MAO. As a conse quence , 
s everal hyclr<J z:i.de c c.:npoun<l s have e sta.bli shed t.hen1se l ve s o n the 
current market as psychothc rapeut.i c drug s . 
Sp ecifically , the objec t of this i nves tigation was to dete rrnine 
whether a newl y synt.he sized cla" s of co:npo1..111ds, i n1idazoJ e carbox -
hydr a:d <lcs , were c apaLle of inhibiting MAO i n vivo, in_ vitro, or 
both. At attern.pt was rn.ade to co rre l ate any in viv~ inhibit.ion of 
MAO activity wi~h blood pressure changes in the event that. hen10 -
dynamic altc rations 1::-e came evident. 
W hile a ciire c t correlation between MAO i nhibition and blood 
pres sure cha nges has no t b;;en establishe d, many re searchers believe 
that tb e h ernodynarnic c:..lte 1 ations se en following the adrnini :stratio11 of 
hyd razide MAO inhibitors could conceivabJy h ave b een produced by 
a n action unre la ted t o i nhibition of this enzyrne system. 
Prelin1inary observations have den1onstrate d the ability of at 
l east one inembcr of t he dihydra?.i.de c01npounds to alter locornotor 
activi ty . Therefore the present. study has i nclude d quanH.talive 
aiterations of central nervous systern. activity . 
B . Mate rials and Metho ds 
I. Blood. Pre_s_12:urc Stl1dy 
a . Direct blood pressure n1.easurernent: Male , adult albino 
r ats of the Spraeue -Dawley s Lrain 1 weighing between 200 -250 gms. 
were ar: .. 1:s th0ti :~e d with Urethan2 , 1. 25 gnu /kg., adrninister e d intra-
pe rilone ,:ii. 1.y. B Joo d pressure was obtained by direct cannulation of 
the left <'aroti.d a ,-l:e ry; a saJine -fi] led tube extending from the (:annul a 
s ~"rved to transn1it pulse pressure variations to a standard inercury 
2 1 
n1anomcter . A g1?.SE.: rider, resting on the mercury menist'.us tr2.ns -
f£.:rr e d this infonnalion into a continuous r e cording on a smo ed kyn-10 -· 
er-c:·:-ih c1rum .. Hepa rin3 was j ntrocluced into a soft r u bb8 r tube directly 
a~·ij;::.t: eut ~o the cannula i n order to reduce clo t f orn1.ation. Tracbeol.:01ny 
w ·:i~; r· c rforn1.e d in1.medi;ct e ly foll owing cannulation of the artery. 
A.11 drugs to be adn1.inistered I. V . were di ssol ved in nonnal ~"ilin~' -
D n~g solutions were prepared in sufficient concentrcttions so that no 
vohr;-nc greater than 0. 50 m l. was injected . AlJ drugs were admi n istere d 
b / dow iruusion i n t o the right fe1no!·aJ. veh1. Blood pressure was 
- -·----·- ··-- --· ·-----·-·-----
1. C h<' : l e s Rj 'C r Br~edi ng F<•.r:ns , Nortb W:ilc1ingl::>n, Mas sacbusetts. 
2. M erck & Co. , Jnc. , Rahw.:;.;·, New Jersey. 
3. Pa nhe i-·rin , Abbott L<lb•:... r<ilorjes , North Chic ago , Illi.riois . 
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b. I ndirect blood pres sure measurement: 1v1a l e , 2_dult 
albino rats of_ the Sprague - D a w l e y strain were grouped i nto two 
and distributed in standard animal housing cages 1 R oom temperature , 
th.rougho:ut the study , wa s n1aintained at 23° C, as n1Casured by a 
Tempsc ribe recording the rrnorn ete r 2 . The roorn housing the anin1.al 
cages waC' ilhirr..3. nat ed for a rni nim.um of 10 h ours daily . 
- 3 
Approxh,1a t ·.': ly 20 g1ns of Purina rat food was offe1· .:.; d to each 
anirnal :taiJ.y at noon . ·water was provided ad li.b_iturn by n :eans of an 
inverte d b ottle with a tubul a r outlet. 
All drugs we re a<lrnini ste reel i n tr ape r itoneally du ring this study . 
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The anin1als we r e weighed d aily on a O haus anin1a l bal anc e , and in-
j e_cted d a ily b etween 9 :0 0 A. M. - 10 :00 A . M . for a p e riod of 21 days. 
Hydrazidc con1.pounds t o be t ested were dissolved in glass-distilled 
watc r in c orn:cntrations of 10 mg /ml and 20 mg /ml . A t the time of 
i n j ection, animals received drugs accor di ng to the following regirnen: 
C OMP OUND JN IV a 
(inrid azole -4 , 5 - dicarboxylic 
acid, di -2. -methylhydrazide) 
5 mg /kg , intraperitoneally d ai ly 
2 0 mg/kg, i ntraperitoneally dai l y 
40 mg/kg, i ntraperitoneally daily 
1. Wahmann Mfg . C o . , Baltimore, Maryland. 
2. Bacharach, Pittsburgh, Pennsylvan i a . 
3 . Ralston Purina , St. Louis, Missouri. 
4. O haus Sea.le Co rp . ·, U nion , New Jersey . 
C OMPOUND Jt II 
(imidazolc -4, 5 ·-dicarbo),.-ylic 
acid , di--2 - dimethylhydra:dde) 
V l<-:HICLE , glass -
distilled water 
5 mg / kg, int rape ritoncally dei.iiy 
2 0 rn_g/kg , intraperitoncal y daily 
40 mg/kg, intraperitoneally daily 
1 rnl / kg, intraperitoneally daily 
T he e ffe c ts o f the dihy<lrazide compounds on systolic blood 
pres s u re were dete rmincd by fnuirect measurement. Prior to the 
actual rcci.ding, the anin1c.. l c ages were 1 cmovcd L-oni_ their iionria 
h abHa.t. a:l'~ plc c e d i n an Envir\)ntro l c onstant te1nper~t.ure c:han:1ber 
rna i ntained at 30°C. T h e d e sign o f t his c hamber allows the main -
tenance of l ow humidity t r e l ative l y high temperatures. Following 
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t heir i ntroduction i nto the chan1.ber , the animals were allov.red one hour 
f o r acclimation prior to blood p r es su :::c detcrni_inatiorn; . 
T he t ail cuff method fo r dcte rrnination of systolic blood pres sure 
w as ut:!.Jized. An inflatable , cir cular tail c uH 1 aUached to a p ressu_rc 
sy sten1. , was slid up the l ength of the t ail and placed approxi1nately 
one i nch f rom the base . A Beckman mic rophonc t rans duce r 2 enclosed 
in a small c lear plas~_ic holder was s li d onto t he tail , adjacent to the 
r ubber tail-cuff. T he p l asHc h older of the transducer in-:orporatcd a 
sc rew cla1np . By manipulating this cla1np , pressure was applied to 
the rat tail , f orcing it into co11tact with the micr-op 1.0ne transducer . 
T he anatoni_i c al structure of the tail itself required con ide rable 
1. Harvard I nstruments, C a1nbridge , Massachusetts . 
2. Beckman C o . , Palo Alto , California . 
n1anipulation to ensure accnrate r eadings . A le ad frorn the phono-
t ransducer was feel into a B e ckn1anlnfraton 1 signal divider; the output 
l ead of this instrmnent was then attached to a HP oscilloscope 2 set at 
a 20 msec / c1n sweep time . 
Basically, pre ssure fluctuations pi.eked up by the phono-
trans(bccr· and C'.1b scquently co nverted into electronic signals were: 
observed as sU.'.H-Hn"!s on an oscilloscope . These lines , or "blips'' , 
s een a.s a se:·ie s of peak~ , could b e obliterated by inflating the rubber 
t ail -cuff which effectively stopped tail circulation . C arefui rnanipula-
24 
ti on of a screw valve decreased the pressure in the m anome ter systen-1, 
allow ing the return of circulation. A s circulation was restored, the 
" bli ps" reappeared o n the o scilloscope screen, The pre s sure re a ding, 
taken directly fron1 the manon1eter at the preci se morn.ent the "blip s" 
reappcci. 1·ed, was considered to be systolic blood pressure, 
Before blood pressures were recorded, the animals were placed 
in a neating box 1nci.intaine d a L 40° C for approximately 20 rn.inute s . In 
t his 1nanner , p eripheral biood vessels could be dilated some w hat, 
thereby facilitating the reading . I rnrnedid.tely follo w ing the heating 
p eriod, each r at \vas place cl into a plastic charnbe r 3 , d e signed such 
I. Beckman Co . , Palo Alto, C alifornia 
2 . Model 130B, H ewl e tt-Packard Co ., Palo Alto, California . 
3. Design ed and const ructed by M.L David Co ates , Dept. of PJ1 arma -
cology, University of Rho<fo l sland. 
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t hat a piston-like apparatus constituted one end, while the opposite 
end was ren1ov2...blc . Thns , b,- 1novi···g the piston toward the re1novable 
partition, it was possible to vary the chamber l eneth to co rrc spon<l to 
t he size of the anim.al. The m .ovable partition was pu l i nto place and 
the piston length ad justed, l eaving only the rat ' s tail extending from 
the cb ci.mb~r. ·G -_· nera.lly, a few m.inutes were required l efore the ral 
b cc!'.rnc .. uf£icicntly caln1 t o allow readings to be taken. 
Blood pressure recordings were taken as the averc..ge of three 
o r more successive detcnninations . The time elapsed be:tween two 
s uccessive dete rn1ina tions varied depending upon the ge ne ral b e havior 
o f the anhnal. 
For the purpose of this prclim.inary stl.idy , 28 rats div ided into 
seven groups of four e ach uncle rwent the daily ]Jrotocol previously 
described . Blood pressure s were recorde d three dri.ys prior to t};e 
administration ?f drug . Beginning on the second day of drug admini s tra-
ti on, b lood pressure was recorded every third day throughout a 21 d a y 
pe :· ] oc . 
2. Monoaminc o x idase studie s 
A preeminent characteristic of hydrazicle MAO inhibitors is 
t hat the maj ority of thes e compounds exhibit MAO inhibition either rn 
vivo or in vitro but not in both . That is, a cornpound showing pro -
nounced MAO i nhjbitory power in an in vjvo syste1n may in f a ct have 
li ltle or uo effect in ar. in vitro sy tern. 1'hel'efore, both in vivo and 
in vitro AO <·tu<lies were perfonned . 
a. I n vivo MAO study: 48 rats we re divided into eight equal 
group.3 as follows: 
G roup 1 
G roup !1 
Group III 
G roup IV 
Group V 
Group VI 
received Nardil 1 (p lt .:; uelzine dihydrogen sulfate ) 
40 mg / kg body weight, i. p . in gla.ss -distilled 
water. 
~ ac1j:fice: 2 ~ours a . .fter injection . 
r eceived glass -distilled water , 1 rn.l/kg body 
weight, i. p. 
sac rificc: 2 hours after inj ection . 
received carboxyrnethylcellulo se , 2 % suspen sion., 
1 ml/kg body weight , i. p. 
s acrifice: 40 rni.nutes after i njection. 
received c ompound JN l Va (2 5 0 mg /kg), in 
c arboxy-methyl-cellulose vehicle, 2 50 rn.g /kg 
body weight , i. p. 
s ac rifj cc : 40 minutes aftc r injection . 
r eceived carboxymethylcell 110 se , 2 % suspension 
i n glass-distilled water , 1 ml/kg body weight, i.p. 
::;acrifice: 2 hours after injection 
r eceived corr«potmd JN IVa in carboxyrneihyl-
c e llulose veb.icJe, 250 mg/kg body weight, i. p. 
~crificc : 2. hours after injection. 
I mrne<liatcly f ollow:i.ng the ti.rne alloted to each group for drug 
2 
activity , the animals were dccapitatc<l . Both liver and brain tissue 
1. Ge nerously supplied by \Varner -Chilcott Labo raiorie s , Morris 
Plains, N. J. 
2. Guillotine, Harvard Instrun1ents , C ambridge, Mas sachuselts. 
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were rapidly removed and homogenized . A. Tri-R Horn0 g;::nize r 1 
equippe d wit!.1 a 'Teflon p~stle was used for this purpose. Since Horita 
(1 965) h a d demonstrated the abiHty of red blnod cell s to antagonize the 
actio ns of known inhibitors oJ. hLL\.O, it was necessary to exsangui nate 
the liver prior to horr,ogeni:dng this organ. This was accon.1.plished 
c c..nw1·; <:•.ting the h epatic artery and pe rfusing tb e entire 
o r ga.~' \•.~it h c old 0. 2 51\.1 sue ro sc soluU on. The o rg<m homo g e n ates 
f rurn. c::ach r :.t '..Vere pla ced in standard 1 2 ml glass tubes and froz en 
at ,.. 40°C u ntil ue:edecl. At the time of assay , the tubes were pJaced 
in a cold water bath until the h ornogena.te s had thawe d con1pletely. 
1. Ass!!_y_ ?J rnonoamine o x.ic~a.s.:; ,:·(:tivi!_y . 
a) Methodolo_g_y. A rnodifi c a tion of the spectrophotometric 
MAO assay of Weissbach~ al. , (1960 ) was us ed for the d eterrnination 
of monoamine ox ida se activity both in vivo and in ~itro MJ\0 studies . 
The basis f or the as say i s the enzy1natic breakdo·wn of kynu r arnine 2 , 
a synthetic ainine . 
ln th e presence of m .onoa1nine oxiclase , kynurarninc is 
1. Tri-R I nstrmnents , J amaica , N ew York . 
2. Kynt;r<cn1ine cli.hydrobron1.idc, Regis Chemical Co1npany, 
C hicago, Illinoi s . 
degraded j n the following manner: 
0 














2, -1- -dihydroxyq;_1i :wlinc 
Absorbance of kynura1n~nc is seen to increase sharp y and n1axi-
m ally at 360 mu . This enzyrn a U c degradation of ky.nuran1ine by MAO 
may rea <lily be follow E:d by spectroph0ton1e tric analysis , and is seen 
as a <lee re ase in absorbance at 360 mu . Convc rsely , as kynuramine 
absorbance at 360 mu decreases, t he absorbance peak of the JJro<luct 
develops at 310-335 mu. This new p eak i s thought to be the spectrum 
of 4-hydroxyqujnoline, the postulated end product of MAO--degraded 
kynuran1ine. 
The tubes of fro zen homogenates were thawed 
and placed in an i11su1ated container fi lled with crushed jcc. This 
procedure was adhered to l argely as a precautionary rneasure , for 
it has been <lcrnonstrated that 1v1AO is an extre mely stable enzy1ne . 
1 
A Beckman DB SpcctrophoLomeLer equipped with a 10 11 record 
1 . Beckn1an Instrmnenls, In c. , FuJlerlon, California. 
1 ing accessory attach1nent was used to follo w the en,,;yme r eaction. 
A te1nperature of 30°C was maintain:-!cl in the cuvette chambe r of the 
2 
sp e ctrophotorncte r by use of a Haake constant temperature and 
circula ting apparatus. Accordingly, all ccn.1.ponents of the reaction 
medium, exc]usive of the enzyrric, were k e pt in a water bath3 1nain-
Al the thn.c. of as say , each coinponen1. of the incub a tion mixture 
was pi.petted into standard, two -sided silica cuvette s . The following 
s cheme rep re sen ts a typical re action mixture: 
Component 
Phosphate buL':er , 0. 5 M, pH 7. 4 
Kynuram i ne, 0 . 3 um 
Waler, glass -distilled 
Homogenate (enzyme source) 
Total volume 
Reac tion A 
Blank 
0 . 3 ml 
2 . 6 ml 
0. 1 ml 
3. 0 r n.1 
Reaction B 
~x~i._1_?:1en tal 
0. 3 rn.l 
0 . 1 inl 
2. 5 inl 
0. 1 ml 
3. 0 ml 
P relirninar y studies we re performed to deterrnine the volu1nc 
of tis sue homogenate required to produce a rninimum c hange in abs or -
b ance of . 100 units per hour . For purposes of the in_viyo MAO study , 
t h e activity of 0 . 1 ml of horn.ogenate prepared from tissues of glass-
1 . Beckn1an Instrun'lents, Inc. , Fullerton , Calif ornia. 
2. Haake , Gerruder, Berlin, Gerinany. 
3 . Arthur H. Thomas , Philadelphia, Pa . 
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distilled water vehicle -·inje cted rats was taken as standard activily . 
A graphical represen tation of the enzyme reacti on. taking place was 
p roduced directly by the recording instrurnent. The li.nc obtained 
fr on-i this graph represented the change in absorbance per unit time 
(minutes ). Data r ecorded for the i nitial 5 -· 10 m·i.nutes was discarded 
due L1:i rccordh1 £ interic1ence cau,;C::d by particl.~~; settling in the 
rea.c ~_io !1 1ncc1.iutiJ· . This problem did not occu1- cl'1l'i11g the in vitro 
stud:i.Ps , •.vh'-!r::. rn:i~;ocho11drial suspensions were used as the enzyn1e 
source . 
In a c cordance with the prescribed metbodology, it was necessary 
to demonstrate a linear rel.atior..sh:.p bct\v en a , sorbancc yers~~ con-
c entration of kynuramine. This wa s accomplished by preparing a 
s eries of solutions of varying concentrations of kynuramine and 
. . 
me.asuring absorbance of these concentrations at 3 60 mu. A c urve 
was then constructed by plotting optical density (absorbance ) readings 
o n Lhe o rdinate versus kynurarnine c oncentration on the abcissa . I n 
this study, the existence of a linear relationship betwe en concentration 
and absorbance was sub stan tiated. 
b. ~n vitr<? MAO study: The origina] procedure o f Weissbach 
e t al. , (1960) for the detcrrninatio11 of MAO activity utilized tissue 
·h on1ogenates as a source of this enz y1ne . However , various w o1+ers 
have shown th at the greatest am.ount of MAO activity is localize d in 
t he mitochondria (Kopin, 195 9; Davi son , 195 7; Hawkins, 195?.) . For 
this re ason , rat liver mi1-ocho1 <lrial suspensions were used as the 
enzyme source throughout the in vitro MAO studies. 
Five rats were killed 
separately by ce rvicc,l cJi slocation. The h e patic artery was isolate cl 
ancl the en.Ure liver was perfused with cold 0 . 2.5 J'vf. sucrose solution . 
T}ic liv er w as p1. 2 ce<l in a chilled 150 ml bea1-:.e 1 ;_~m;. ·..,vashe d until the 
dec21Jt (, d supe1·•! •"1:ant re1n<:.ined clear , then pl2.ccc_ h1 50 ml glass 
tub :; s. The live :-· \vas then hornogenized using <:tpp.r:oxinl.ate ly a 
1: 41nixture of tissue and sucrose solution . The homogenates were 
pooled , distributed in equal volumes to eight 50 inl polypropylene 
tubes, and c entrifuged 1 al 3, 000 rpm £or 10 .min-..ites . Th~ resulting 
supernatant was de canted, divided into ej ght additional tub .:! s and 
c entrHugecl at 3 , 000 rpm for 10 nl.inutc;:>. The supernatant was c are-
fully decanted, distributed to eight tube s and centrifuged a third tirn e 
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at 7, 000 rpm for 10 minutes. The supernatant was discarded and the 
r esultant pellet washe d with 2 . 0 ml of . 25 M sucrose . A total of 20 inl 
of -sucrose was- .used to· transfer the pellets into two tubes whi ch were 
then cen trifuged at 11; 500 rpm for· 10 1n.inutc s. The supernatant was 
disc arded and the pellet resuspended in 48 nil of 0. 05M phosphate 
buffer, pH 7 . 4 . The final suspension was redistributed i nto 2 ml 
aliquots, placed in standa r<l 12 nil gla ss lubes and sLored at -40° C. 
1. Servall Refrigerate d Centrifuge, Mo<lel RC-2, Sorvall, Inc. , N . J. 
At the tin'le of a s say, one or more tubes containing mitochon-
dri a l suspension were allowe d to t haw iii. a cold water b ath. Certain 
m odifications in prepa ring tbe reactionn-ft.xtt'..re were reqni.1 ed . All 
c omponents of the reaction mixture, excluding the subs trate , kynur -
amine, were incubated with either known inhi bitor or compound IVa 
fo :c a specified pr·i-iod pri oJ:" to the addition of suhsfrai:e . 
3. Prol~in content determina tion: The method of Gorna ll 
et ~1.: , (1949) was used for the colorimetric dctc ::.·n'lination of the 
p rotein pre sent in an aliquot portion of rnitochoncll'ial suspension. 
This method proved to be particularly uc:efo l i n determining protein 
c ontent in crude tissue homogenates. A t the time of assay, 1. 0 ml 
of mi.tochondr ial suspension was plpeticcl into a standard 12 ml glass 
tube , to which was added 4 . 0 1nl of biurel reagent. The con tents were 
. dl m1xe , allowecl to stand for at ]ca st 20 minutes, and then p aced in 
silic a cuvette s . 
2 
Readings were taken on the DB spectrophotorne ter 
at 540 inu against a blank containing 1. 0 ml of water i n place of lhe 
rrutochondria} SUE'pens ion. 
Bovine serum a lbuinin3 was u sed in the preparation of ttandard 
1. Vorlcx Junior, Scientific Industries, Inc . , Springfie ld, .tv1.as s . 
2. Beckrnan Instr Uinents , Inc., Fullerton , California. 
3. Armour Pharn'laceutic a l Co ., Kankakee, Illinoi s . 
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c urves . This was accompli.she cl by preparing several ce>ncentrations 
of standard protein as follows 
Reagent Se l'i~tl .Dilutions 
I 2 3 4 
B ovine albumin (10 mg/ml) 0. 1 ml 0 .2 ml 0. 3 ml 0 . 4 rnl 
Wav~r, glass distilled 0. 9 m l 0 . 8 ml 0. 7 m.l 0 . 6 rnl 
Biu rc l re2.genl 4 . 0 rnl 4 .0 rnl 4 . 0 ml 4 . 0 ml 
The readings nbtainecl from this series were plotled on graph pape1., 
a nd a standard curve was constructed from which the protein content 
of all other samples could be determined . 
The rnethod for cletermining protein content of homogenate 
samples prepared during the in vivo MAO as says followed the p 1·0 -
c edure de scribed above . 
C alculation of Turnover Rate . The change in ab so rbance ove i.. 
a 2 0 minute period was reacl directly from the plot obtaini:::d from the 
r ecorder during a typical reaction period. By simple ext apolation, 
the change in absorbance per hour was calculated. This value , 
divided by the slope of the kynuramine standard curve 1, expressed 
t he c hange in absorbance per n1icro -rnole of k~,rnuramine free base . 
Thi.s value , when subsequently divided by the prote~n concentr a tion in 
33 
a particular sani.ple , re pre sen ts a rate of substrate turnover expressed 
I . See Assay of MAO activity; Procedure , page 28 
as µmo] e kynuramine /hr /mg p ·otein . 
3. Activity Studies 
To measure locon1otor a ctivit)' in mice , and drug-induced 
changes therein, a photoe lectrically equipped cham.ber 1 was em.-
ployed. This charnber , a circular cage, contained 12 symmetrically 
pl <:iccd ape rc>.tur~ s, each loc ated apprcxilna ·e ly one -half inch above 
the g:dd-lil<o flo o l"ing. Six of these openings were equipped to e1nit 
electric light beams, each of which crossed the diameter of the 
c harnber, and focused on one of the sjx r e ceiver aperatures, where 
the signal was picked up by photoelectric cel1 lying directly behind 
the receiver . Thus, six .separate and con.1.plete photo -electric 
circuit s existed in the chamber . An electric counting r:necha:nis n1 1 
was attached to the Actophotomele r unit. As long as the six photo-
electric circuits rern.ained intact, nothing was registered on the 
counter. Howeve:;:-, if any circuit was broken by an interruption of 
the light beam, a signal was sent to the digital c ounting mechanism 
and was registered as a nurnerical change. 
Procedure: Male, albino mice 2 weighing 20-25 grams we re 
u sed throughout the study . E a ch experimental group of five mice 
was hou sed i n separate cages; water and food were provided 
1. Actophoto1neler, Metro Scient ifi c, Inc. C arle Place, L. I., N. Y . 
2. Cha rles R iver Bree ding Farms , North Wilrningl·on , :tv1as s. 
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ad li bi tum, except when specified by the expe rirnenla l de sign. All 
groups us ed o n any particular day were f asted 24 hours prior lo 
' 
-tr eatment . 
Recording periods dtiri.ng b'.)th Series I 2.nd Se ries II extended 
~hrough 11 :00 A. M. - 1 :00 P . M. In Serie s II, when the i"irne interv 1 
fr mn trcatrnen1 to recording of locomotor ci. clivi~y was 2. 5 h ours , 
a nimals were iHj ec l e d from.10:00 A.M. to 10:30 A.lvL in order that 
ac tual recording periods would coincide with those of Series I. 
I l F'ollovving d r ug or vehi c le tr eatment , anfrnals fro m each 
I 
I <l d h . . . B h <l t reate group were returne to t. e1r respe ctive cages. ot rugs 
I 
I 
tJNIVa and Phcnclzi nc ) and vehicle (ca1·boxymethylcellulosc ) were 
admini stered intraperitoneally. Phenelz ine and JNIVa were suspe nded 
I 
in a 2 per cent s-olution of carboxym e ihyh: e Jlulose and i,,vere kept 
! 
I 
froz en untiJ needed. 
I 
In Series I, 1 hour was allowed t o e l apse for drug activity, if 
[
ny , to take place . In Series II, 2. 5 hours was allowed prior to 
ecording . Imrne<liately following this allotte d period, the five 
I 
I 
rnimals of each group were placed into the Actophotometer; the 
rounter was started and recor<ling of activity commenced . Total 
t:unmlative counts ""'ere recorde d every 5 rninule s throughout I . 
I 
the 30 n1inule observation p e riod. At lb e t ermination of each 
counting period, each experin1.ental group was returned t o its 
re speciive cage . Following its entry (use ) in the Actophotornete r , 
no group was scheduled for reu se for at least three days . 
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IV . RESULTS 
A LL TABLES AND FIGURES ARE CONT AfNED IN THIS SECTION. 
TABLE I 
TERMINAL MONOAMINE OXIDASE ACTIVITY: IN VP/O DRUG ACTIVITY 
- --
A. RAT LIVER HOMOGENATE 
-· 
Protein Terminal 
Elapsed time content of MAO acti v;i. ty 
Drug before homo gPn ate- umol kynur amine / 
Group Administration Dose sacrifice ( /. . \ mg ,:::::"11 1 hr /mg protein 
la-L Phenelzine 40 mg/kg, 2 hours 3.20 0 
1 b-L i. p. 3.40 0 
2a-L 3 . 75 0 
2~-L 4. 60 0 
3a -L 3 . 50 0 
3b -L 2. 75 0 
4a - L 3.2 5 0 
4'::> - L 2 . 55 0 
5a - L VEHICLE: 1 ml/kg , 2 hours 1. 70 20 . 4 
5b -L water, glass i. p. 3 . 50 9. 3 
6a -L distilled 1. 55 21. 0 
6b -L 2 . 95 13. 2 
7a - L 2. 80 13. 1 
7b - L ~ .... t; 
- · t...- 9. 7 
8a -L 4.30 9. 8 
8b -L 3. 90 10. 7 
9a -L VEHICLE: l ml/kg, 40 min. 3.20 10. 5 
9b -L car boxy - i. p . 2. 95 10. 7 
lO a -L methylcellulose 3.30 11. 4 
lOb -L {2%) 2 . 90 13 . 4 
lla -L ?.. 80 13 . 2 
llb -L 3. 90 11. 7 l,.; 00 
Group 
12a - L 
l 2b - ' .... 
13a - L 
13b - L 
14a - L 
14b-L 
15a - L 
16a-L 
16b-L 
l 7a - L 
l 7b - L 





20b - L 
2la - L 
2lb - L 
22a - L 
23a - L 
23b - L 
TABLE I (Continued) 












250 mg/kg, 40 min 
i. p. 
1 rr-.J. / kg, 
i. p . 
250 mg/kg, 
i. p . 
2 hou rs 
2 hours 
TABLE II 
SUMMARY OF TABLES I AND II 
MONOAMINE OXIDASE ACTIVITY: IN VIVO DRUG ACTIVITY 
---
A. RAT LIVER I-IOMOGENATE 
--
Group I Group .II Group III Group IV Croup V Group VI 
--
D rug 
treatment phenelzine vehicle: vehicle: a JNIVa v eni cle; JNIVa 
water CMC CMC 
e f 
Time 2 hrs . 2 hrs . 40 P-lin. 40 min. 2 hrs . 2 hrs. 
""Tb 
.i 'i 8 8 6 6 8 7 
+ c X - S. ·D. + 0 . 34-4. 72 +· 13.4-4. 7 + 
.L 
11.8 - 1.2 14.6.:.2.2 il.4±1.2 + 12. 4 -2. 3 
STATISTICAL COMPARIS O N OF GROUPSd 
Comparison 
Group I, phenelzine vs. Group II, Vehicle ; water 
Group II, Vehicle; water vs. Group III, Vehicle; CMC 
Group III , Vehicle; CMC vs Group IV, JNIVa, T-40 
GroupIV, JNIVa, T - 40vs. Group VI, JNIVa, T-120 
G!'oup V, Vehi.c.!.e; CMC.: vs. Group VI, JNIVa , T-120 
a .. CMC; carboxymethylcellulo se , 2% . 
b . N = Numbc r (.•{ rats. 
c. mean-±: S. D. 0£ MAO activity expressed 
in umol kynuraminc /hr /mg /protein. 
N. S. =no s ignificarit difference, P 0. 05 . 







d . Con~parisons made by use of 
Student's :1t 11 test. 
e. 12 0 minu::cs duration oi action 







2b - B 
3a - B 
3b-B 
4a - B 
4b -B 
5a - B 
5b - B 
6a-B 
6b -B 
7a - B 
7b - B 
8a-B 
Sb - B 
9a - B 
9b - B 
lOa ·-B 
lOb -B 
l la - B 
llb -B 
TABLE Ill 















40 mg/kg, 2 hours 
i. p. 
l ml/kg, 








conte ~ t 0£ 
homo .;0112 "f: e 
(mr.: / rn! ) 
_ _,__._... __ ---
2 . 75 
2.85 
2. 90 






2 . 90 










2 . 95 
2. 90 
Termi.nal 
MAO a c tivity 
um.cl kynuramine / · 















2 . 7 
3. 3 
3. 1 
3 . 0 
3. 4 
3.0 
2 . 8 
.., 1 




12b - B 
13a - B 
13b - B 
14a-B 
14b - B 
15 a - B 
J6a-B 
16b - B 
17a - B 
17b - B 
18a- B 
18b-B 
19a - B 
19b - B 
20a-B 
20b - B 
2 la - B 
2lb - B 
22a - B 
22b - B 
23a - B 
23b - B 
TAB LE III (Continued) 









A. RAT BRAIN EOMOGENATE 
E lapsed time 





i. p . 
250 mg/kg, 






SUMMARY OF TABLE III 
MONOAMINE OXIDASE ACTIVITY: IN VIVO DRU G ACTIVIT Y 






-+ c X - .S . D . 
Group I Group II 
phenelzine ve"'::J.icle: 
water 
2 hrs. e 2 hrs. 
.3 8 
0 2 . 93·t. 38 
Group III Group IV 
-- --~ - ·--
vehicle : JNIVa 
CM Ca 
40 min . £ 40 rnin . 
6 7 · 
3. io±. 20 3 . 42."± .3 6 
-
STATISTICAL COMPP, R ISON O F GROUPSd 
Comparison 
Group I, phcnelzine vs . Group II , Vehicle; water . 
Group II. Vehicle; v:ater vs. Group III, Vehicle, CMC. 
Group III, Vehicl.e , CMG vs . Group IV , JNIVa , T - 40 
Group IV, JNIVa , T - 11,0 vs . Group VI, JNIVa, T-120 










2 hrs . 
8 
3 . 2-±.81 
Group VI 
JNIVa 
2 hrs . 
8 
3 . 31-± . 53 
r.i. . carboxy-methylceJ lulo se . d. Student's "t 11 test, Snedecor, 19 56 . 
b . N =number of animals per group . 
c. Mean-!: S tanda rd Deviation of MAO activity 
expressed in urnol kynuramine /hr /mg protein . 
e. 12.0 minutes duration of action . 




FIG. 1 TBE EFFECTS OF JNIVa AND PHENELZINE ON TERMINAL 
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HOMOGENATE~ 
Each bar represents the: n1ean ± S. D. turnover rale of n1ono;imine 
oxidaf'.c obtainec! frorn iver hon1ogcn~-t.lcs of rals pretreated wj!.h 
· v ehicle , JNIVa, or phenclz ine . 
Drug Tre atrncnt: 
_Yc·hiclc, ~M-~(carboxymethylcellu1ose) 1 rnl/kg, 
i. p.; Waler , g_lass_-clistillccl, 1 m] /kg, i. p.: 
JNIV a , 250 mg/kg , i.p.; Phcncb:inc_, -10 n1g/kg, 
i. p. 
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B R AIN HOMOGENATES 
E ach b ar represe nt s the m e-a. ± S . 6 . turnover r ate of n1onoan1 i nc 
oxi da se obtained fr on1 brain h omogenates of rats prcl r eate c \\:i th 
v ehicle , J NIVa , o r p hene l zine . 
D rug treatment: V chicle, CMC ( c arboxymethylcellulo se } 
1 ml/kg, i . p .; 
Wale r , glass-distilled , lrni/ke, i.p . ; 
J NIVa , 2 50 mg / kg / , i . p.; 
Phe n .lzine , 40 mg / kg, j. p. 
Tin1c i nterval prior t o sacnfjce: -iO min\Jlc s and 120 minutes 
Time (s ec ) 
TABLE V 
THE STABILITY O F 
MITOCHONDRIAL M O N O AMINE O XIDASE 
OVER A FORT Y -FIVE MINUTE PERIOD 
POOLED RAT LlVEH. :MIT O CHO NDRIA 
·======·--· 
Optical D ens ity (OD) 
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· chan g e j n 
optical d ensity/ 
15 minute pc riod 




l I 90 
1355 
1424 























0 . 29S 
0.286 
0.2 80 














60 . D. 15 = 0.0 74 
6 O.D. 15 = 0. 080 
60.D.15 = 0.0 68 
TABLE VI 
THE ST ABILITY O F 
MITOCHONDRIJ-. :.., MON OAMINE OXIDASE 
OVER A F OR TY -FIVE MINU TI:: PERIOD 
POOLED RA'I LIVER MITOCHONDRIA 
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Optical density {OD) 






0 . 2 39 




c hange in 
optical density/ 
15 minute pc r iod 
6 O.D. 1 5 = 0.070 
·------- - ---- -·-- ·- - ------ -- ·· 
S e ric s II: Segrnenl 






0. 1 98 
0 . 185 
B 




0. 11 4 
6 O.D. 15 = 0.075 
6 0. D. l S =- 0. 07 1 
TABLE VII 
THE STABILITY O F 
MITOCHON DRIAL MONOAMINE OXIDASE 
O VER A FORTY-FIVE MINUTE PERIOD 
POOLED RAT LIVER MITOCHO NDRIA 
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---·-----~ 
Optical Den~ity (OD) 
- ··---- ---· . --····------------- ---
Series III: Segment A 

































S e ric s Ill: Segment B 
0.2 65 
0 . 245 
0.23 9 





Series III: Scgn1ent C 
0. 185 
0. 150 
0. 1 35 
0. 11 5 
change in 
optical density/ 
1 5 rni.nute p e r i.od 
6 O.D. 1 5 = 0. 071 
. 6 0.D . 15 = 0.080 
60. D. 15 =0.070 
S ample 
TABLE VIII 
SUMMARY O F TABLES V, VI, AND VII 
M ITOCHONDRIAL MONOAMINE OXIDASE 
OVER A FORTY-F IV _t-: MINUTE PERIOD 
P OOLED H.AT LIVER MITOCHONDRIA 
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------ -------------
S eries: I 
----·-- --------·- ---·---- ---------- ---
..:: ._c A 
.Je g j'.nen ,. 














0. 074 i: 0 . OO(J 




S egrncnt C 
S ericE": lLT 
0.071 
0.0 80 
0.0 70 0. 073 ~ 0. 005 
a. Change in optical density (absorbance) per 15 minute period . 
b. Represents 111.ean-±: S. D. of 6 0 . D. 15 values obtained in each 
series. 
c. 15 minute portion of o erall r eaction . 
STATISTICAL COMPARISON O F SERIES 
Serie s Con1.p a ·i son 
Se rie s I vs. S e ries ll 
Series I vs . Seri .:. ,; III 
S eries lI vs . Series Ill 





0. 05. Con1parisons macle 





THE EFFECTS OF JNIVa AND I'HENEL ZINE D'G·IYDf{OGEN SULFATE 
. ON MONOAMINE OXIDASE AC TIVITY. 




3. 14 x 10 M 
-7 6. 28 x 10 M 
8 ,.. . o-7 7. '.)xi M 
-7 9.40xl0 M 
- 6-
1. 36x10 M 
-6 1. 57 x 10 .M 
-5 
1. 55 x 10 M 
-6-
3. 10 x 10 M 
- 6 4 . 71 x 10 1\1 
6 -6 . 27 x 10 M 
-6--
7. 75 x lO M 
-6-
9. 4 2 x 10 M 
111 • , ' , • • 
/0 li t-1 1·~ :)1 L1rJ n ~~~~·-~~~~~-=-Iso value 
21. 6 ± 
4-0. 5 





c...3 . 8 





8. 3 x 10 M 
-6 5.4xl0 M 
----------- -------· ----
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FIG. 3 THE EFFECTS OF JNIVa ON MONOAMINE OXIDASE l\CTIVITY 
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FIG. 4 THE EFFECTS OF PHENELZINE DIHYDROGEN S ULFAT E ON MONOAMINE OXIDASE 
ACTIVITY 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1. 2 1. 4 l. 6 





























'1,EIE EFFECT OF lNCREA.SED PRE:INCUBATJON 
TIME ON THE l NH;DJT ION OF MONOAl\1.INE _ 6 




T1 - _l 
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FlG. 6 ACTOPHO TOMETRIC RECORDING GF GROSS 
LOCOMOTOR AC Tl VITY 
NlEAN. CUMULATIV:C 
COU NTS 
[ . J + 1 = X - S. D . total c umulati\·e 
counts . 











400 - '-------0----· 0 4 
200 - ~2 
;---__.. __ ___,_ _ ___._ _ ___,_ _ J ___ l-=J 
0 5 10 15 20 25 30 
TIME (MINUTES) 
Gr aph rep re scnts n1c a n cun1ul aii ve c ounts per five mi nnte increm0.nt 
generated by six groups of five vehic l e-treated n1ale a lbjno 1nice 
over a period of thirLy minutes. 
Dr~ trcat~1c_:1_,t : V chicle ( ca.rboxymcthylccllul o se), l ml/kg , i . p. ; 
1 h ou r d uration of action . 
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FIG . 7 ACTOP -IOTOMETlUC RECORDING OF GROSS LOCOi\10TOR 






2 200 __ _ .,
?.OuO 
1800 
1 6 0 0 --
1400 -
o X ~ S . D. total cumulative counts. T 
0 = C Value(%) : C oefficient- of Variation . L ) 
-1--
1 
1200 C VALUES(%) 





~...i---.... J_______ __._ __ _..._ ____ !,__ , __ ..... 
] 
0 5 10 15 20 2 5 30 
T IME (MI N UT ES) 
G raph rep re senls me an curnu laLi ve counts pc r fiv e nrinutc i n crernent 
gen.c rated by six groups of five phene lzine tr eate d male albino ini ce 
measu re d over a p er i od of thi rly minutes . 
Drug 1:2·catme1~~ Phenelzinc, 4 0 mg/kg, i. p.; ] hr. duration of 








FIG. b ACTOPHOTOMETRIC RECORDING OF GROSS LOCOMOTOR 
ACTJVITY 
O = X - S . D . total cunrn.l ative C(junis . 
O = C Value(%) : C oeffic i ent of Variation . 
M EAN CUMULATIVE 
COUNTS 
1600 








0 5 10 15 20 25 30 
TIME (MINUTES) 
G raph represents n1ean cunl.ulativc counts per five minute incren1ent 
generated by six groups of five JNIVa treated m .alc albino n1i.ce 
n1casu r c d over a p eri o d of thirty nl.inutes . 




























= X ± S. D. total c.um.ula.tive count s. 
r·- O =: C Value(%): Co efficient of Variation . 
r 
0 5 10 15 20 
TIME (MINUTES) 
C VALUE.:3 (o/o) 
o---° ~ 10 9 





Graph reprcsenis m ean cumulative coun ts per five minule i ncrenieni 
generated by six groups of five phe nclzine treated male albino mice 
measured over a period of thirty Ininules . 
Dr~ i reatmenl: Phen e lzine, 40 mg /kg , i. p. ; 2. 5 hours du ration of 
aclion. 
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2 0 00 f 
1800 - ··· 




8 0 0 
6 0 0 




=: X - S. D . totalcurnul ativecounts . 









·--L ,_....__ __ , 
0 5 10 15 20 25 30 
T I ME (MINUTES) 
G raph represents mean -t S. D . curnulative counts per fi v e rninule 
i ncrem.cnt ger..cralcd by six groups of five JNIVa treated male albino 
n1.icc measured over a pc riod of thirty nunutc s . 
D rug treatment: JNIVa, 150 mg /kg, i. p. ; 2 . 5 hours du ration of 
action. 
5 9 





- · + 
= X - S. D. 1.otal cunml a 1ive c ounts , 220 0 
0 - + = X - S . D .. total cumu] ati ve c our1ts ; 2 000 
J:'N!Va 
1800 ~ · -








0 5 10 1 5 20 
TIME (MINUTES) 
____ !_. 
2 5 3 0 
G raph represents mean curnulative counts gencrale cl by six groups o f 
fi ve vehicle treated ma.le albino mice versus six groups of five JNIVa 
tr c ate cl n1ice . 
D n.:.g_ treabne12_t: Vehiclc(ca.rboxyrnethylccllulosc) 1 m l /kg , i. p ., 
J NIVa , J 50 mg/kg , i. p . 
Time j nte1va] prior 1.o .!":_ecording: 1 hour . 
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= X - S. D. tota l c un1ulative counts; vehicle 
0 = X ± S. D. to ta l cumulative counts; phenelzine 
_J l 
10 15 20 25 30 
TIM E (MINUTES) 
Graph rep re sen ts ml" an cumulative counts gen.~ rated by six group9 u f 
fi ve vehicle tre ated mal e albino mice versus six groups of five 
p hcnelzi11e treated rnicc . 
Drug treatment: Vehicle(carb oxymeLhylcellulosc ) 1 ml/kg , i . p.; 
Phcnchine , 4 0 mg/kg , i.. p . 
Time interval prior to r ecording: l h our 
bl. 
FIG. 13 ACTOPHOTOI\1ETRIC REC OH.DI -,ye OF GH.OSS LOC0l.'v10TOH. 
ACTIVITY 


















= X - S. D . total curnulat:i.ve counts; vehicle 
-+ 
::: X - S. D. to tal cu1nulaiive counts; 
i~-·- .~1 ~---~J~~.__~L_~~~----
0 5 10 15 20 25 30 
TIME (MINUTES) 
+ Graph represents rncan - S. D. cumul a tive counts per five minute 
inc rcirient gene rated by six groups of five vehicle trea tf:d nlalc 
albjno mice versus six groups of five JNIVa treated mice . 
Dru g treatment: Vchicle(c a:.:boxyrn.etbyJcellulo sc ) 2%, 1 rnl/kg, i. p.; 
JNlVa, 150 mg/kg, i.p. 
Time interv al prior to ~co~clin_g· 2 . 5 hou rs . 
FIG. 14 
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= X - S. D. total cumulative counts , vehicle 
- + 
= X - S. D . total cumulative counts ; phenelzine 
\..------' ---~L__ ........ I  __ .. ___ L __ ---1..... 
.5 10 15 20 25 30 
TIME (MI NUT ES) 
G raph r epresents mean cumulative counts per fiv e rninute increment 
gene r ated b y six groups of five vehicle treated male albino n1ice 
versus six groups of five phenelzine treated n1ice. 
Dru g treatment: Vehicle( carboxymethylccllul osc ; 2%, l 1n l/kg , i.p .; 
P henelz:lne, 40 n1gh:s, i. p . 
Time in t~rval prio~ to -::_~E .. ~_:rc'ling: 2. 5 }:our::. 
F'lG. 15 .ACTOPHOTOMETRJC RECORDING OF' GROSS J .OCO!V10TOR 
ACTIVITY 





2 000 - --
1800 ---· 
1600 










- S . D. tota l climulative counts; J NJ.Va 
- + 
= X - S. D . total c u rn ula live counts; phcnel zinc 
}------'-----'-----.J._J~---'--.---Jl ___ l __ 
0 5 10 15 20 25 30 
TIME(MINUTES) 
Graph r epresents rnea n -~ S . D . of cu1nulativc counts per fi ve mi n u le 
inc rcment gene r ai..cd by six g r oups of five JNJVa l rcalcd male albino 
mi ce vc r sus six groups of five p11c:nelzine lrealc d n1icc . 
Dr_~1g l r ea12ncnt: JNIVa, 150 mg/kg, i.p.; phcne l zinc , 40 mg/kg. i. p . 
Time intc:~Y~l prio::_!_~ re cor di ng: 1 h o u r. 



















- + 0 = X - S. D . total curn.ulative c ou!1ts, JNIVa 
- + 0 = X - S. D . total curnulative c ounts ; phenelzine 
___ ....__ __ _J_ 
0 5 10 15 20 25 30 
.TIME (MINUTES) 
Graph represents mean-!: S. D. cum.ulative counts p er fi ve mi.nute 
i ncrement generated by six g roups of fi.ve JNlVa treated male albino 
rni ce versus six g r oups of five phencl zine treated mice . 
Drug treatE1 er:_1:_: JNIVa 150 mg/kg, i. p.; phenehine, 40 mg/kg, i . p. 


















F IG. 1 7 ACTOPIIOTOMETRIC RECORDING OF GROSS LOCOMOTOR 
ACTIVITY. 
M EAN CUMULJ\TIVE 
COUNTS 
0 - + = X - S. D. total curnulative counls; JNIVa 
Q - + = X - S. D. total cumu1ativc counts; phenelzine 
1 ...._ _ .. ___ L 
5 10 15 20 
TIME (MINUTES) 
G raph rep re sen ts mean curnnlative coun ~ s pc r five 
generated by six groups of five JNIVa treated male 
six groups of five phenelzir1e treated Inice. 
25 30 
minut.e increment 
a l bi no mice vc r s us 
Drug treatment: JNIVa 150 mg/kg, i . p.; phenelzine 40 mg/kg, i. p. 
Time inte~~ prior ~~ding: JNIVa: 1 hour 
Phcncl zine: 2 . 5 hours 






0 = X ± S.D . tota l curnu l ative count s ; J NlVa 
2200 D - + = X - S. D . tota l cmnula tive counts ; 












._...__ _ _ l._ L_ . _ _J_ 
0 5 10 15 20 25 30 
TIME (MINUTES ) 
Graph represen ts mean~ S. C. of Jnean curr.u 1lativc collnts pe r five 
m inute i ncre1ncnt generated by six groups of fi ve JNIVa tre ated 
male albino mice versu~ six groups ·of five phc n e l zine treated mice . 
Dn~ treatme_nt : JNJVa , 150 mg / kg, i.p.; phenelzine , 40 mg / kg, i.p. 
Time interval prior t o recor_9j.E_g: JNIVa: 2. 5 hours 
phenc l zine: 1. 0 hours 
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- + 0 = X - S. D. total cumulative counts; JNIVa; 1 hour 
- + [3 = X - S. D. total cumulative counts; JNIVa; 2. 5 hrs. 
0 5 10 15 20 25 30 
TIME(MINUTES) 
Graph represents mean~ S. D. of mean cumulative counts per five minute 
increment g e nerated by six groups of five JNIVa treated (1 hour ) male 
albino mice versus six groups of five JNIVa treated (2. 5 hours ) m ice. 
Drug treatment: JNIVa, 150 mg /kg, i. p. 

























~l\ ___ _..6. 
4G O - . A 
~..r~n-_ 
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___ ·_ _L__L . I __ 
5 10 15 20 2 5 30 
TIME (MINUTES ) 
• 
Graph re pre sent~ mean segmente d counts per five n1inute in cren1ent 
generated by six groups of vehicle-treated, JNIVa-treated and 
phenelzine - treated 1nale albino mice over a p eriod of thirty rninutes. 
Dru g ~reatmcnt: Vehicle, CMC(c a rboxymethylc e llulos e ) 1 rnl/kg., 
i. p.; J NIVa , 150 ~g/kg , ·i. p . , phcnel zinc , 
40 mg/kg, i. p. 

































ACTOPHOT01v1ETRJC RECORDING OF GROSS LOCOMOTOR 
ACTIVITY 
] __ -r 
__,__ _ _, _ __.. __ _L_ 
5 10 15 20 2 5 30 
TI A.E(MINUT:SS ) 
Graph represents n 1ean scgrncntcd counts p e r five minule incren1enl 
gene rated by sj x groups of vehicle -l rea ted , JNIVa-trc ate cl and 
· phen-clzine-lreaLcd male albino.IYiicc over a pcrjod of. thirLy n1inutes. 
Dr~g_ trea~nent: Vehic] e , CMC( carboxymelhylccllulo se ) 1 ml /kg, 
i.p.; JNIVa, 150 mg/kg, i . p.; phcnc]zinc, 



















FIG. 22 ACTOPHOTOMETRIC RECORDING OF GH.OSS 
















5 ] 0 15 20 25 30 
TIME (MINUTES) 
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Graph represents mean segmented counts p c r fiv e n1.i nutc i nc r e1ncnt 
generci.ted by si x group s of vehicle -treated , JNlVa-treatcd ( 1 hour 
duration) and J NIVa -tre atcd (2. 5 hours duration) mal e albi no mice 
ovc r a p~ ri9q_ of thi r t_y n 1.i nute s . 
D r1'g treatment: Ve hicle, C MC(carbox y 1nethylcc llulose ) 1 m l/kg , 
i. p., JNJVa, 150 mg/kg , i. p. 
Tirnc i nterva l .erior ~recording : 1 hour and 2. 5 hours 
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~ ...------PHE NELZINE (2. 5 hrs . ) 
~-'\ [~--PHENELZ?N~ J\ 
() ~- r· (1 hr . ) ~:r--'"· .;-.,.~ 
'i:.1------D--._r:i 
'-~1-- ........_ . 










,.__ _ _J ___ ._J ___ _J !_ _J 
10 15 2 0 25 30 
TIME (MINUTES ) 
Graph r e p re sen ts mean segmented counts per five minute increment 
gene r ate d by six groups of vehicle - treated , phenelzi ne - t r eated 
(1 hour d u r a lion} and phenehine -t reate d (2. 5 hours dur a t ion} ove r 
a p eriod of thirty minutes . 
Drug treatrn.ent: Vehicle , CMC ( carboxyn1cthylcellulo se ) 1 ml /kg, 
i. p., ph enelz.ine, 40 mg/kg , i. p . 
TimE'. interval prior ~?_~ccording : 1 h our and 2 . 5 hours 
T A BLE X 
T HE EFFECT OE' J NIVa AND PHENELZINE TREATMENT O N 
G ROSS LOCOMOTOR ACTIVITY IN MALE ALBINO MICE 
---------------
A . I nci dence of sign jficant diffe r ence beb.veen drug - treated and 
v ehi..::le - lrcated groups of mice , using tolal segmented c ounts per 
fi ve minute increment for a period of thi.rly minutes . 
S eries I: JNIVa versus control (vehic l e ) 
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d if.fe rence 
------------- · ·---
- + X - S.D. 
I 
5 45 8 : 43 
10 41 6 -f 18 
X - S. D . 
42 5 : 91 
3 26 ± 104 
a 
N . S . 
N. S. 
15 3 82 ~ 52 + 225 - 104 b Sign. 
20 385 + 4 ~ - J 
25 37 6 ~ 60 
30 3 64 : 45 
X = Mean 
S. D . = S tandard deviation 
19 8 ~ 7 5 
182 ~ 7 6 




a. Fo r a given five minute period , gross locomoto r activity as 
m easured by the actophotome ter was not significantly (N. S .) 
d i fferent or , 
b. s ignific antly different (Sign.) as compared to the a ctivity of 
v e hicle - trealed groups . (P < 0 . 0 5 ) 
D rug tre atment: V e hicle , CMC (carbox yme thylce llulos e ) 1 ml/kg , i . p. 
J NIVa , 1 50 mg/kg, i. p . 
T ime inlerva l prior to recording_: 1 hour 
T he meant S. D. of the tola l cun-mlalive counts p e r five minute 
in cre1ne nt was c o1npute d . Cornparisons b e twe en vehicl e- treated and 
d rug-treated groups were made by n1eans of Stud enl 1 s 11 t 11 t es t 
(Snedec o r , 1956) . All values were computed by use of the IBM 
M ode] 1620 Digi ta] C omputer (Unive rsi ty of Rhode Island Computer 
Labor ato ry }. 
TABLE XI 
THE EFFECT OF JNIVa AND PHENELZINE TREATMENT ON 
GROSS LOCOMOTOR ACTIVITY IN Jv1ALE ALBINO MICE 
B. Incidence of significant. difference between drug -treated and 
vehicle -treated groups of mice, using total counts per five nlinule 
incren1enl fo1 a period of thirty minutes. 
Serjcs E: JNIVa ~rsn:; control (vehicle) 
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Time (rn.i.n) Control vs. Drug-tr eated 
Incid ence of 
signifi can1 
diffe r e nee 
- + 
X - S. D. 
+ 5 458 - 43 
10 416 : 18 
15 382 7 52 
20 385 ± 43 
25 376 ~ 60 
30 364 ±- 45 
X =Mean 
S. D . =. Standard deviation 
- + X - S.D . 
348 :±- 99 
362 ~ 50 
249 ± 94 
170 :.t- 127 
258 ~ 68 
43 9 :_!- 72 
N.S.a 
N . S . 




a. For a given fiv e 1ninute period, gross lo comolor activity as 
me asured by the actophotometer was not significantly (N.S.)' 
differen t or, 
b . signifi canlly (Sj gn.) cEffe rent as compared to activity of vehicle·-
lrcaled groups . (J.->~ 0. 05) 
Dn g treatment: Vellic.le, CMC (carboxyrncthylcellulose) 
JNIVa, 150 mg/kg, i. p . 
Time interval prior to ~cording: 2. 5 ho.us 
i l/kg, i. p. 
The n1.ean 2· S. D. of the tolal counls per five minute incre1nent '.vas 
computed. Co1npari sons bet.we en vehicle -l re ate cl and cl rug -lreatccl 
groups were rnade by means of Student's "t" test (SnedC'cor, 1956). 
All valuec.- were computed by use of the IBM Model 1620 Digita Computer 
(Uni v c rsily of Rhode Island Computer Laboratory). 
TABLE XII 
THE EFFECT OF JNIVa AND PHENELZINE TREATMENT ·O 1 
G ROSS LOCOMOTOR ACTIVITY IN MALE ALBINO MICE · 
C. Incidence of significant difference between drug-treated and 
vehicle-treated groups of mice, using total counts per five minute 
increment for a. period of thirty minutes. 













- + ~ - S.D. 
458 ± 43 
416 :!- 18 
382 ± 52 
385 -t 43 
376 ± 60 
364 ± 45 
S. D. :o: · Standard Deviation 
- + X - S.D. 
480 :±- 25 
440 ± 58 
441 ± 60 
434 ± 94 
405 ± 120 
414 ± 87 





N . S. 
a. For a given five minute p e riod, gross locomotor activity as 
measured by the actophotometer was not significantly (N. S.) 
different. 
Drug treatment: Vehicle, CMC (carboxymethylcellulos e ) 1 ml/kg , i. p. 
Phene lzine, 40 mg/kg, i. p . 
Time interval prior to recording: 1. 0 h our 
The mc :i.n ± S. D . of total counts p e r fiv e minute increment was cornputed 
C ornparisons b e tween vehicle -treate d and drug-treated groups were ni.ade 
by means of Studcni '.s "t" tes t (Snedecor , 1956). All values were 
computed by u se of the IBM Model 162 0 Digital Compute r (Uni,·ersity of 
Rhod e Island Cornpuie r Laboratory) . 
TABLE XIII 
THE EFFECT OF JNIVa Al\D PHENELZINE TRE.ATMENT ON 
G ROSS L OC OMOTOR ACTIVITY 11\i MALE ALBINO MICE 
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D. I ncidence of significant difference behwee n drug-treated and 
v ehicle - treated groups of mice, using to Lal counls p er five minute 
inc r c 1nent f or a p e riod of thirty rninute s. 
Sc ries IV : Y:'henelzine versus control (vehicle ) 
~I' i me ( n-!L ) _____ Cont r o l vs Drug - treated 
Inc i c:ence of 
significant 
di ffe renc-::' 
- + X - S.D. X ! S.D. 
5 458 ± 43 557 + 3(, Si gn . 
10 416 ± 18 496 + 55 Sign. -
15 382 ± 52 489 + 57 Sign. -
20 385 ! 43 4 56 + 80 N.S. 
25 3'/6 ± 60 469 ± 65 Sj gn. 
30 364 ! 45 4 4.4 ! 63 Sign . 
- ----- - ------------
X = M E:an 
S. D. ::;; S tanda rd deviation 
a. For a given five minute pe riod, gro ss locomotor acti ity as 
measure d by the actophotomcte r was not s ignificantly (N . S .) 
d ifferent or , 
b. significantly (Sign.) different as compare d to activity of vehicle -
treated groups . (P .::;: 0. 0 5) 
b 
a 
Drug treat1nenl : V e hicle, C MC (carboxyrnethylcellulose) 1 111] /kg , i. p . 
Phene l zine, 40 mg/kg , i.p. 
Time interval E_rior~ rC' cord)ng : 2 . 5 hours 
The rnean -!: S. D . of total counts per five minute incre1nenl was con1.puted . 
Comparisons be tween vehicl e - treated and drug -tre ated groups were mad e 
by m eans of Student 's "L" te sl (Snedecor , 1956). All value s we re 
con1.pulcd by u~e of the I DM Model 1620 D i gi.tal Cornpu{e r (Unive rsily of 
Rho cl ~ Island C omputer Laboratory ). 
V. DISCUSSION 
Mono amine oxi das e studie s: In vitro sys tern 
The meihod of Weissbach et~!_., (1960) for the determination of 
mono aminc oxidase activity was used throughout thi.s portion of the 
study. Through preliminary studies , it was determined that the 
a s say nH~thod was a1nenable to the use of 1n1tochonc ·ial suspensions 
as well a s cr:..12e homogenates for a source of MAO, for which the 
a ssay was originally designed . 
All but two of the initial five compounds presented for research 
were elinunated following preli1ninarr enzyme studies. Of the 
two rernaining con1pounds , JNIVa was a..railable in sufficient 
quantity to allow completion of additional studies . 
Various authors (Hawkins, 1952; Davi s o n , 1957) have indic a ted 
that the major activity of MAO is found in the mitochondria. 
Baudhuin et al. , (196 4 ) r eported that 74% of the total MAO activity of 
c rude rat live r homogenates was loc alized in the m.itochondria, v.rith 
24% in the microsomes. Inasmuch as Zeller ct~. (1955) demon -
strated that mono amine o xidase of tis sue h()mogenate s in conside rably 
l ess sensitive than mitochondrial MAO to the a c tions of even 
relatively potent inhibitors such as iproniazid, frozen suspensions 
of lysed rat liver mitochondria we re used as the enzyme source for 
all in ~tro MAO as says 
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Early work in this area (Z eller~ al, 1955; Davison, 19 56; 
G reen, 1962) has established the requisite for a pre -incubation period 
to effe ct maxim.a l inhibition of mitochondriai :N1AO; in,deed , th e extent 
of enzyme inhibition has been obser,red to i ncrease with l onger incu-
bation periods. I n studies preliminary to the present one,_ an attempt 
was rnade to der.nonstratt:: the existence of a sirnilar r e l ationship 
between in_ vi lr'.:! 1\.1-AO inhibition and cornpound JNIVa. A concentra-
tion of 4. 7 x 10-bM JNlV a was found to b e capable of e ffective inhi -
bilion of approximately 50% of mitochondrial MAO activity . Figure 
5 rep resents graphically the results obtained when reaction rn_ixlure s 
were run, keeping the arc.ou nt of en7.yme and drug constant, whjle 
".arying the length o f the incubation period. With the same drug 
concentration , it Yvas possible to alter t he degree of enzyme in hi bi-
tion from virt11all) none (a negligible amount) to over 7 0 per c ent , by 
increas i ng the incubation p e riod . The degree of enzyn1e inhibition 
r ose rapidly during incubation p edods extendjng to 20 minu tes . A t 
thi s point, a "plateau" r egion was reached, which ex tended from 20 
to 40 minutes of incubation time . The plateau was f ollo-,,ved by a 
second , relative ly sharp increase in the degree of inhibition elicited 
b y t he t est c ompound. This pattern for co1npound JNIVa was thus 
shown to be very sirnilar to those of knov..n i n vitro MAO inhibitors . 
In this study, preincubation ti1ne was found to be a controlling factor, 
as is the c ase V'.--ith such classic MAO inhibitors as iproniazid and 
phcnyl-i sopropylhydr aziJJ.e (PIH}. However , Zeller et~~ (J 955) 
reporte d that maximum MAO inhibitior!. produced by iproniazid was 
reached between 6 and 12 minutes, whereas the degree of enzyme 
i nhibition elicited by JNIVa was still increasing even after a 60 
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mi1111te incubr.'. ion pe:::-iod. If the assumption that preincubation pedods 
are r eqnir(:·d f·~·.r the biotransforn1.ation of the drug into an active 
inhibitor is valid , it would follow that a longer time interval may b e 
r equired for the active moiety of compound JNIVa to be release d. 
Howe ver, m e chani sm studies a re needed to substantiate this 
hypo the sis. 
The effects of the simullaneous addition of enzyme , subs Lr<tte, 
and inhibitor to the re action rnixture correlate d well with li terature 
r eports ob tained from similar experiments u sing iproni azid . Under 
these conditions (no preincubation period), JNIVa was inefiectiv::: ln 
i nhibiting MAO . This fact suggests that compound J 1\fJVa could 
elicit its in vitro inhibition of MAO by acting as a c ompetitive 
i nhibitor , although substantiation of this idea awaits furthe r studies. 
Before any further: i.::. ::=itro enzyme studies were perfonned, a 
definite schedule for reaction inixture s had to be devised. A-;1 
incubation interval was needed sue h lhat. slight variations in the 
schedule would not appreciably affect the <le ree of enzyrn.e inhibiti on , 
b ecause preinc"t:bation time was shown to affect t11e inhibitory ac tivity 
of JNIVa le a st significantly duri ng the 20 to 30 minute incubation 
ir~terval. A period of tv.ro lninutes was requir<:!d to remove t!-te 
reaction cuvettes frorn the wc.~ter bath, pipette 0. 1 ml of kynurarnine 
into the media , cover with parafilm, and mix by vigorous shaking . 
At<:>. tii:r.1e w1:(;n enzyme h1hibition h ad been shov-.-n to be incre asing 
r api.dly \.vit'1 e 1-' e n small changes in time, this tv, ·o -rninute p c r.i.od 
c ould conceivably have a signific ant effect on the re sults. A p e riod 
whereby the degree of inhibitlon \Vas least affected by tin.1.e would 
effectively guard against di sc repan cies caused by experimental 
t~chnique . Th e 1.-cfo re, it was decided that a preincubation tirne of 
20 minutes would be suitable for this purpose . 
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A lthough J NIVa had seemingly d ecrease d the rate of kynurami11e 
oxidation taking place in mitochondrial as well as in crude rat liver 
homogenates, it was of primary in1portance to establish that a true , 
drug-induced inhibition and not a degradation of the enzym.e itself 
was the causative agent in the observed decrease in substrate oxida -
tion . A study was designed whereby the stability of the enzy1ne 
preparation, mitochondrial suspensions, would be detennined . 
Three separate reaction mixtures containing no i nhibitor we re 
allowed to react for 50 minutes each. The change i n optical density 
p er 15 minute increment ( 0. D . is ) was determined by dire ct 
m~asurement obtained frorn graphs produced by the DB -Spectr o -
p hot.ometer recording attachm.ent previously described (See Methods 
s ,_~ction , p age ~ ) . Table VIII smnn1ad zes the results obtained 
fr om Series I , II, and III of this study . Statistical cornparison of 
r esults obtained from each series demonstrated that n o significant 
c'1.i.ifo 1·ence ex~ s t ed between the activity C>f mitochondrial MAO 
:m.easun~d dul'~ng the first 15 minutes of incubation at 30°C, when 
compared t o val ues obtained f ro1n the second and t hird 15-ininute 
s egments of the total reaction time . The i ntegrity of the enzyn1e 
p:i:eparation -.,vas i.m.affected by incubation periods extending for over 
50 rninute s . In lig}1l of these findings , it was as si.m1ed that the 
80 
c hanges noted in enzyme activity following JNIVa m .ust be attributed 
to t he action of the drug i tself and not lo any l oss of enzy1ne integrity. 
A separate study was use d to deterrnine the effect on the degree 
o:f enzyme inhibition unde r c onditions of constant ten1perature brought 
about by varying enzyme c oncentration, drug c onc entration , and 
p reincubation tirne . All enzy me r eaction-s were run at 3 0°C usinz-
a pre incubation time of 2 0 ininutes. Figure 4 dernonstrate s the 
d ose -re spC>nse re l ationship obtained with phenclzine . A similar 
r e l ationship was observed when compound JNIVa was used as the 
i nhibito r. A dose -1esponse c urve was drawn by plotting the 
c oncentration of inhibiLor on the abcissa and per cent i nhibition on the 
81 
ordinate . From this graph, it was then possible to determ.ine the 
r50 value (approxjmate couccntration at ·.vhich 50 per cent inhibi tjon 
of enzyme is observed) for each drug. T he 150 value for phenebine , 
a known inhibi tor of monoamine oxidase in vivo and in vitro was 
-7 -6 found to b e 8. 3 x 10 M as com.pared to 5. 4 x 10 M , the 150 value 
detennh~-~d £0 r JIJIVa . Table IX lists the various concentrations of 
e z,ch drug a sc d in the detern1ination of 150 values . Based on these 
d ata , it would appear that compound JNIVa exhjbitcd significant 
JviAO inhibiting properties, when compared under similar ·conclilion s , 
t o the actions of pehnelzine, one of the 1nore potent -hydrazine MAO 
inhibitor s known at pre sent. 
ln YiY.Q. MAO studies 
The observation that hydr azide -type MAO i nhibitors exlnbiti ng 
potent inhibition in one system. while being inactive in ·anothcr h as 
b een well documented (Schaye r and Smile, 1953 ; Weikel~ a~, 1963; 
Zeller ~t al, 1955 ). C onsequently , the fact that compound J NIVa 
d emonstrated rat er potent MAO inhibitory p roperties ii: v i tr~ by 
no 1neans dictated that si1n ilar results were to be expected in vivo . 
An in vitro 1neasurcment of in vivo drug a ctiv ity was m ade by 
d etermining the extent to which liver an<l brain hon~ogenates of 
t reated rats cou]d metaboli7.e the substrate , kynuran~inc , using the 
id entical assay n~cthod for all n~casuretnents ·of enzyme activity . 
This part of the study was dividc<l into two series, A and B . 
All animals in Series A were sacrificed 40 n-Unutcs after .tre &tment; 
anhnals in Series B were sacrificed 120 minutes after treatment. 
During preliminary studies, it was found that treatment with 
vehicle, whether glass distilled water or 2 p er cent carboxymethyl -
c ·..:- llulo.se, adn:.1nistered at either of t hese thne periods, h ad nu 
signi.ficant effed on enzyme acti rity. It was therefore decided to 
run one control for each vehicle at the 40 rninute period, in order to 
decrease the nun1ber of animals sacrificed on the day tissue homo-
genates we re to be prepared from treated groups. 
During a separa te prelirninary .;,luciy, it was noted tha t both 
rat s and mice treated with 100 mg/kg JNIVa, intraperitonealJy, 
showed profound sympton1 s of lethargy and developed ptosis, 30 to 
45 minutes after drug administration. For this reason, a decision 
was n1.ade to sacrifice at least one entire series of drug-treated 
groups at a time when drug effects we re evident. Neither the 
sedative nor ptoiic effect of JNIVa was as pro1nine nt after 90 minutes 
had elapsed from. time of treatment ;_ however, it was beli eve.cl that at 
least two hours should be allowed for any drug activity, particul_a rly 
MAO inhibition, to become manifest. 
R eports 0£ alrn.ost tota l inhibition of brain_ and liver MAO 
following a sii1gle intraperitoneal in.fection of hydrazicle MAO 
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inhibito rs are not uncom .... -inon . McNeill (1 964) found that phene l zine 
.\30 ing / kg) wa=> capable of virtually c omp1ele inhib..i tion {97 . 5%) of 
brain MAO ac tivity in rats treated \vi th a singl e injection three 
hours prio r: to sacrifice . Weike l et al, (1 96 2) reporte~l tha t o ne hour 
after a si11 gl.e intraperitoneal inj e ction of iproniazi<l, 15 0 mg /kg, 
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73 p e r c ent of b-::ain MAO an<l 100 per c ent of liver MAO was inhibited . 
It b ecarn.e clear, th en , that hydrazi ie MAO inhibito s a re c a p able 
of signific antly lowering MAO activity after single dos e s have b een 
ad1nini s te r e d. 
For the purpose of lhis study , e xpe rimental groups were 
divided in the rnan.'1er previou s ly describe d (See Methods section , 
page ~ ) . Once the animals had been s acrifi c ed an d the tis s ue 
homogenates prepared, the actual measurernent of MAO activity was 
p erfo rmed exactly as in i n vitro measurements, the only exception 
b eing that tissue h omogenates f rom. treate d anin1al s we re now u sed 
as the enzyme source for the as say. The protein content of each 
liver and b rain ho1nogenate sample was detenninc..d . Tu1·nov e:r r ates , 
expres sed as )lmole s kynura1nine /hour /Ing p rotein we re calculated 
from these data . Table II suIDmarizes the data obtained f ro1n 
a nalysis of turnover r ates b ased upon MAO activity of livers obtai ned 
fr om treated rats. These r esults are re presented graphically i n 
Figure 1. The inean turnover r ate for all phe nelzine treated groups 
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was zero , signifying tha t t he dr ug h ad completely inhibited the 
e nzyme present in both liver c.•.nd brain. Convers e ly, compound 
J:NIVa failed to bring about a significant change fron"l t he control 
value of the activity of liver or brain monoamine oxidase in rats 
t reated 120 minutes prio r to sacrifice. When c ornpare d to a inean 
cont::::ol va.lue o..: 11. 81 t 1. 23 , the activity of liver homogenates 
p reparec :r.Jn"l JNIVa-tre ated animals showe d a sm.all but significan t 
inc rease . Similarly, mean turnover r ates of 3. 42 "± 0. 36 and 
+ 
.3. 31 - 0. 5 8 are reported for groups treated with JNIVa 40 m .inutes 
a:::i.d 120 minutes prior to sacrifice , respective ly (T abl e IV). The 
enzyme acii.vi ty of both JNIVa-treated groups was shown to b e 
r aised above control values, though neithe r change was st a ti sticaJly 
si gnificant. C ertainly, th.e effects of JNI Va on an in vivo en z yme 
system den10ns trated in this study, when conside red i n light. of the 
in vitro enzy.1.ne activity ell cited b y the drug, would not b e expe cted 
to occur. Elucidatio n of this seeming anomaly mu st await addi t i o nal 
study. 
It is evident from this study that compou n d JNIV a failed t o 
e xhibit any signifi c ant i n vivo i nhibit.ion of monoaminc o x idase, an 
effect clearly de monstrated by this drug during in vi t ro enzy1ne 
studies using similar assay techniques . 
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Activity Studic s 
Early in the activity studies, numerous rne chanical difficulties 
were encountered i n the use of the Actophoto1neters in this laboratory. 
O nce the instrument h ad. been adjusted, great c are was required to 
maintain all six photocle ciric circuits in functioning order . Follow-
ing a.dju str:1cnt, the instrument pr0ved to b e a valua b le 1.ool in 
dt~kr:n1.in:i.ng the temporal pattern of animal activity subsequent to 
drug treatment. 
The extensive studies performed by Watzman et al, (1964 ) to 
determine in what way the actophoto1netric method of measuring 
gross locor.noto:· activity could be en1plo y.::.d nwst efficiently proved 
valuable in de signing the pre sent study . Watzman' s work may be 
sununarized as follows : 
1. The l owe st "C" values (Coefficient of Variation) anc highest 
c umulative counts resulted fro1n the use of five mice p er experimental 
group . 
2. Higher cum ·lative counts were generated by fasted mice as 
opposed to mice which h a d been fed prior to the recording period . 
3. " C " values were found to be lowest during the first half-hour 
of the counting period. 
4 . Any "warmup" 01" equilibration p e riod prior to recording 
would tc;;nd to i ncrease the "C" values and decrease the total c un1ula -
t ive com1ts obtained during the stu dy. 
Gylys and Muccia (1 967) noted a biphasic action exhibited by 
B<-:!veral hydra zine and non -hycl:razLJ.e 1'v1AO i nhibitors: either an 
i n crease or a slight depression in gross lo comotor activity in mice 
appeared one hour after phenelzine treatrnent; however , after two 
h ours, a very pronounced increase in activity was noted . In an 
attc1n pt to e~~tab~ish a clearer picture of activity changes elicited 
by bo'.:h pl1ena.h:.1ie and JNIVa , t wo separate time intervals of 
1. 0 hour and 2. 5 hours following drug trea.trnent were allowed prior 
t o the recording period. 
The toial curnulative counts gene rated by each experimental 
group were recorded every five minute s for a total of t!-iirly minutes . 
O nly the initial thirty 1ninute period following each group 1 s intro -
duction in the cha1nber was analyzed, because it -..;;·as believed that 
this time p~riod would produce the most meaningful r esults . The 
results obtained during this study were ana]yzed by two methods: 
a) The Mean "i: Standard Deviation (S . D. ) t~tal cumulative 
count s per five ininute increment was calculated for vehicle -treated 
and drug-treated grouf'S. "C" values were det.errnined . 
b) The Mean "t Standard Deviation (S. D. ) segmented counts 
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p er five minute increment were determined for both vehicle-treated 
and drug-treated groups. Statistical comparisons o_f the above group 
were made and the incidence of significant difference betwe e n groups 
was detennined. 
Figure s 6 - l 0 rep re sent the m e a;:is ""!: standard de\i-i.ations of 
the total cun1ulative counts gene rate d by six groups of vehicle -treated 
animals. Included are the "C" values for each five n1inute incre1nent 
For vehicle-treated groups , the number of counts i ncreased linearly 
with tinic t.hc ci.:~~hout the thirty-minute j.'ecordjng period . Furth . .:1-, 
the 11 ("..:" value for each five -minute increment was found to be 
significantly lower in comparison to corre spending "C 11 values from 
drug-treated groups. After ten minutes had elapsed, the "C" 
values drop?e <l to approxima.tely 5 per cent and varied only slightly 
during the remainder of the recordi ng period. It was evident from 
this control study that any drug-induced changes in locomotor activity 
would be easily discernible by the 1nethod employed. 
Graphs of the data fro1n phenelzine -treated groups showed 
linearity similar to the graphs of the activity of vehicle -treated 
groups . However, total cmnulative counts generated by phenelzine 
group s treated 1. 0 hour prior to recording were slightly above con-
trol values (Figure 12). Experimental groups treated with phe:neJ -
zine 2. 5 hours prior to recording (Figure 14) a ] so showe d similar 
inc reased activity. "C" values for both phenelzine -treated groups 
were higher tha n those for vehicle -treate d groups . Values ranging 
from 5 per c ent to 14 per cent for phenelzine -treated , as compared 
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to a range of 5 per cent to 9 per cent for vehicle -treated groups, 
were noted. The total mean count per thirty nunute s for phenelzine -
treated groups at the 1. 0 hour and 2. 5 hour intervals was 2600 and 
2 900 counts, re spectively, as cornpared to 2300 counts generated by 
vehicle-treated groups . 
During the thirty-minute recording period, JN IV a. groups 
trc a.ted 2.t the l. 0 hour and 2. 5 hour intervals generated a t otal of 
15 00 and 1800 counts , r espectively, as corn pa red ~o a mean control 
value of 2300 counts . This significantly decreased locom.otor 
activity experienced by JNIVa·-treated groups was accompanied by 
l arge "C" values for all six r eadings observed during the thirty 
minute recording period (Figures 8 and 10, Results section) . "C" 
.values ranging from 16 to 31 per c ent we re reported f or the six 
J NIVa groups treated 2. 5 hours prior t o reco rding . The dep:::essed 
locomotor activity evident in the first series of J NIVa-treated mice 
was less prominent 2. 5 hours following drug treatn1ent. 11 C 11 values 
within this sc rie s incrr::a secl steadily throughout the recording pc r iod. 
It is pos sible that the depre ssive effect initially elicited by JNIVa 
was now ebbing . Varying duratjons of drug activity caused prirnarily 
b y norn~al intraspecie s variation could conceivably account for the 
extremely high 11 C 1 ' values noted during this series. Interestingly, 
Steinberg-~ al. , (19 64) r eported that r ats of the. sa1ne strain , . sex, 
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and litter often derno:nstrate v.ri cely varying :responses to several 
MAO inhibitors . 
Figure s 6 through 9 represent the total cumulative counts 
generated by drug-treate d groups as oppos e d to vehicle -treated 
g roups. Both phenelzine- treatecl groups generated significantly 
higher cmJnh;: <.LS com .pared to control va.1ues . When c on1p a red to 
these s CJ..rr;..:, cOJJtrol values , JNlVa - tre ated groups generated fewer 
c ounts at both the 1. 0 hour and 2. 5 hour intervals . 
Measuring the activity of drug-treated groups at both t he 1. 0 
h our and 2. S hour interva ls Tnade it po ssible to <le tennine whether 
any changes in d rug effects h ci.d occurred b etween the two tir:ne 
i ntervals . I n addition , qualitative changes in gross locomotor 
a c tivity elicited by phene l zinc and JNIVa could h e observed at both 
time intervals . The results of this study are represented in 
F igures 15- 1 9 . After 30 minutes, a m ean total of 2600 counts and 
2 900 counts was g e nerated by rats treated with phenelzine, 1. 0 hour 
and 2 . 5 ho•.J.rs , respectively , prior to recording of activity . Unde r 
i dentical conditions , JNIVa-treated groups gener ated 1 500 counts 
a fter one hour and 1800 counts after 2 . 5 hours . These r e sults 
would indicate that the stimulation e ·perienced by phenelzine -
t reated groups 1. 0 hour follo vving drug treatment had increased in 
intensity 1. 5 h ours after the jnHia l reading. In contrast, the 
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depression of l ocomotor activity evidenced in J NIVa-tre ate d rats 
1. 0 hour after treatment was not as apparent at the 2. 5 hour interval. 
In order to obtain a n1ore concise picture of the <lisshn.ilar 
lo comotor alteratio11s experienced by the phenelzine - and JNIVa-
treal:ec1 g.r.01Ji?S, rnean segmented counts of these groups were 
an2lyz. ·~d. Tables X - XIII Jist Lhe occurrence of signifi.cant 
diife .r ence3 (P 0 . 5 ) i n gross locomotor activity betwe en drug-
treate d and vehicle-treated gYO'...lps . The d::i.ta are repres e nted 
graphically in Figures 20 - 23 . At the 1. 0 hour time interval, 
significant differences occurred at the 1 5 , 20, 25, and 30 1ninute 
seg1nent s during stu.die s on JNIVa-treatcd groups. At the 2. 5 hour 
interval, only the 14 and 20 minute segme nts were statistically 
differe n t from control group s . I n contrast , no signific ant differences 
o ccurred betwee n phenelzine - and vehicle -treated group s at the 
I. 0 hour time interval. However , at the 2. 5 hour inte rval, all 
e xcept the 20 minute s egment proved significantly diffo rent from 
c ontrol value s . The profiles of both phenelzine gro1.1.ps we re very 
similar (Figure 23 ) , whereas those of JNIVa-treated groups demon-
s trated cons ide r abl e variation when measured at two sepa r at e tirne 
-
i ntervals. At the 1. 0 hour interval, a steadily increasing depression 
of locomotor activity was noted; hov.:ever , a decrease follo wed by a 
c orrespondingly rap id incre ase in activity rising above control value 
occurred during the 30 minute re cording period al the 2. 5 hour inter-
v al. All phcnelzine -treated gr0ups den.1.ons tratc. d an elevation in 
locomotor activity . The intens ity of this apparent stimulation 
remained r elatively stable throughout the recording period. 
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VI. SUMMARY .AND CONCLUSIONS 
A study of certain biochemical and pharmacological pr ope rti e s 
of one me1nber of a serj es of di hydrazides is presente d. This c om -
pound possesses a clos e structural relationship to known inhibitors 
of mo11o arc,ine oxida.se . Con sequently , the p re sent stu<ly was 
d esigned to dud date any phannacological properties of the dehydra-
zide correlating with several properties inherent in hydra zidc- tyri e 
MAO inhibitors. 
A. Preliminary blood pressure studi es were performed, utilizing 
b oth direct dnd indirect measuren1crils. C 1.) D:1pouncl JNIV a (imida.zolc-
4, 4-dic arboxy~ic acid, di -2-rnethylhydrazide) and JNII (imidazole -4, 
5-dicarboxylic acid, di-2 -dime thy lhydrazicle), a dminis tc:red intra -
venously, did not significantly alter system.ic blood pressu re. 
Sinlilarly, compounds JNII and JNIVa failed to alter systemic blood 
pressure when administered intraperitoneally at doses of 5, 20, and 
40 mg /kg daily for 21 days . 
B. The monoamine oxidase assay of Weissbach et al (1960) was 
employed throughout all enzyme studies. Phenelzinc dihydrogcn 
sulfate, a potent hydrazine -type MAO inhibil:n, was used as the 
standard for bolh in vivo and ii:_ vitr<? enzyme studies. Terrninal MAO 
activity ni.easured in brain and liver was not affected by pretreatment 
with JNIV a administered 1. 0 hour and 2. 5 hours prior to sacrifice . 
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Under identical conditions, phenclzine completely inhibited MAO 
activity in boLh liver and brain. 
c. -6 A concentration of 4 . 7 x 10 M JNIVa was found to inhibit 
approximately 50 per cent of mitochondrial monoamine oxidase. The 
degree of inhibition for any given inhibitor concentration was fou nd 
to be chrectly related tot.he duration of the pre-incubation period. 
D. Gross loccnl.·~)tor activity in mice was measured by the actophc..Lo·· 
metric method. Recordings of exploratory activity of animals pre -
treated with phenclzine or JNIVa were taken 1. 0 hour or 2. 5 hours 
follow:i ng drug administration . Phenelzine was shown to 1ncrease 
activity at the 1. 0 hoLtr level; after 2. 5 hours, the iuitial st:imul2.tion 
increased in intensity . Cornpound JNIVa significantly depressed 
explo ratory activity al the 1. 0 hour level; however, this decrease was 
not as apparent al the 2. 5 hour level. "C'' values were significanLly 
higher in JNIVa-treated groups at both time intervals. The mech<inisn1 
o f this depression is not known. Inasmuch as the results of the present 
study delineate the inability of JNIVa to inhibit MAO in ~iv~, it is 
possible that lhe depression of exploratory behavior caused by the 
drug is unrelated to any MAO-inhibition property of this cl rug . 
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